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ABSTRACT
Ceramic, metallic, polymeric and composite materials are generally used as
biomaterials in order to improve human health. In addition to desired mechanical
properties of biomaterials, biocompatibility is important in the treatment or replacement
of body parts. Prior to the introduction of new biomaterials to the market, detailed
biological tests are carried out to prevent any undesired side effects in the body. Both in
vitro and in vivo tests are applied initially which is followed by the evaluation with
clinical trials of the biological safety and performance.
The aim of this study was to examine some biomaterials in biological systems.
For this purpose, the effects of ceramic, metallic, polymeric and ceramic composite
materials with different chemical and surface properties on the viability of peripheral
blood mononuclear cells (PBMC) by trypan blue exclusion method, on the proliferation
of PBMC by incorporation of bromodeoxyuridine to DNA in the proliferating cells and
the activation of PBMC by MTT test were investigated. Furthermore, the effects of
biomaterials on the secretion of proinflammatory cytokines (IL-1α and IL-6) from
PBMC were examined by using ELISA kits. The alteration of conductivity and pH in
different solutions were determined to elucidate dissolution properties of ceramic
pellets. In addition, AMES test (Salmonella typhimurium reverse mutation test) for the
determination of mutagenic potentials and the agar diffusion method for examination of
anti-bacterial effects of biomaterials were applied. Adhesion of pathogenic bacteria to
the surface of biomaterials was investigated by staining bacteria and examining under
the optical microscope.
Except for HA 800 °C pellets, all samples showed positive results for
biocompatibility compared to the controls without biomaterials. The dissolution of HA
800 °C pellets in the culture medium changed the ionic environment that led to a
decrease in the viability, proliferation and activation of PBMC. However, BSA-coated
HA 800 °C pellets increased the cell viability with respect to uncoated HA 800 °C
pellets. Polished metallic samples and other metallic and polymeric samples showed
high percent cell viabilities during 48 hours. After 72 hours, most probably because of
released ions and particles to the environment, a decline in the viabilities of PBMC was
determined. A negative correlation between increasing extract concentration and the cell
vviability was observed for all ceramic samples especially after 48 and 72 hours
treatments.
Cytokine secretion analysis after treatment of PBMC with biomaterials indicated
that HA 800 °C, HA-Alumina 1250 °C and HA-Zirconia 1250 °C pellets led to a
decrease in IL-1α secretion and BSA-coating of HA 1250 °C, alumina 1450 °C and
zirconia 1450 °C resulted in higher levels of IL-1α with respect to the control and BSA-
coated HA 800 °C pellets in the presence of LPS. Stainless steel, titanium alloy and
cirulene pellets caused low levels of IL-1α secretion. In addition, BSA-coated HA 800
°C pellets increased IL-6 secretion compared to uncoated pellets. In metallic samples,
low IL-6 levels were obtained with and without LPS stimulation.
Moreover, the proliferation and activation of PBMC in the presence of
biomaterials were evaluated. HA 800 °C, HA-Alumina 1250 °C and HA-Zirconia 1250
°C samples had inhibitory effects on the proliferation of PBMC in the presence of Con
A. In the activation of PBMC, HA 800 °C and HA 900 °C samples showed the lowest
values at all incubation periods. Moreover, other ceramic samples showed lower cell
activation than the control cultures after 48 and 72 hours treatments. In addition, the cell
activation was observed at 24 hours after treatment with the ceramic extracts at low
concentrations.
Furthermore, investigation of dissolution properties of ceramic samples
indicated that only HA 800 °C pellets led to significant increases in the conductivity of
cell culture medium and deionized water. Moreover, a slight increase in the pH levels of
solutions was obtained in the presence of HA 800 °C samples, but not in the other
samples.
Finally, none of the extracts of biomaterials in PBS had mutagenic effect on
Salmonella typhimurium TA100 strain when they were compared to the mutagenic
material (sodium azide) and the negative controls. In addition, all tested ceramic
powders, ceramic pellets, metallic and polymeric materials had no anti-bacterial effects
on both gram-negative strains (E. coli, P. aeruginosa, K. pneumonia, Proteus spp.) and
gram-positive strains (S. aureus and S. pyogenes). In bacterial adhesion studies, it was
found that surface roughness and other surface properties play important roles for
attachment, adhesion and formation of  biofilm by bacteria on the surface of material.
As a result, although the ceramic samples sintered at low temperatures resulted in a
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decrease in the viability of PBMC, all tested biomaterials showed positive results for in
vitro biocompatibility evaluation.
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ÖZ
Seramik, metalik, polimerik ve kompozit malzemeler genellikle biyomalzeme
olarak kullanõlmakta ve insan sağlõğõna önemli katkõlarda bulunmaktadõr.
Biyomalzemelerin istenilen mekanik özellikleri yanõ sõra, bu malzemelerin
biyouyumluluğu vücut parçalarõnõn tedavisinde ve değiştirilmesine oldukça önemlidir.
Yeni biyomalzemeler piyasaya çõkarõlmadan önce, vücut içerisinde istenilmeyen bir
etkiye neden olmamalarõ amacõyla detaylõ biyolojik testlere tabi tutulmaktadõrlar. İlk
olarak vücut dõşõnda daha sonra vücut içerisindeki testler yapõlmalõ, bunu takiben klinik
denemelerle malzemenin biyolojik güvenilirliği ve performansõ tespit edilmelidir.
Bu çalõşmadaki amacõmõz bazõ biyomalzemeleri biyolojik sistemlerde
incelemekti. Bu amaçla ilk olarak değişik kimyasal ve yüzey özelliklerine sahip
seramik, metalik, polimerik ve seramik kompozit malzemelerin insan periferik kan
mononüklear hücrelerinin canlõlõğõ üzerindeki etkileri trypan mavisiyle boyama metodu
ile, periferik kan mononüklear hücrelerinin çoğalmalarõ üzerine etkileri
bromodeoksiuridinenin DNAya bağlanmasõnõn tespiti ile ve mononüklear hücrelerin
aktivasyonu MTT metoduyla incelenmiştir. Ayrõca, biyomalzemelerin inflamasyonda
rol oynayan IL-1α ve IL-6 sitokinlerinin kan hücrelerinden salgõlanmasõnõ nasõl
etkilediği ELISA kitleri kullanõlarak araştõrõlmõştõr. Seramik örneklerin değişik
solüsyonlar içindeki çözünürlük özelliklerinin aydõnlatõlmasõnda elektriksel iletkenlik ve
pH değerlerindeki değişim baz alõnmõştõr. Test edilen biyomalzemelerin mutasyona
neden olup olmadõğõ AMES testi ile Salmonella typhimurium suşu kullanõlarak ve anti-
bakteriyel etkileri agar difüzyon yöntemi kullanõlarak incelenmiştir. Patojen bakterilerin
biyomalzeme yüzeylerine adezyonunun tespiti için yüzeydeki bakteriler boyanmõş ve
optik mikroskop altõnda incelenmiştir.
HA 800 °C peletleri dõşõnda bütün test edilen malzemeler biyomalzeme
içermeyen kontrollerle karşõlaştõrõldõğõnda pozitif sonuçlar göstermişlerdir. HA 800 °C
peletleri hücre besiyeri içerisindeki çözünürlüğü ortamdaki iyon dengelerini etkileyerek
mononüklear hücrelerin canlõlõğõnda, çoğalmasõnda ve aktivasyonunda azalmaya neden
olmuştur. BSA ile kaplanmõş HA 800 °C peletleri kaplanmamõş HA 800 °C peletlerine
oranla hücre canlõlõğõnõ arttõrmõştõr. Parlatõlmõş metalik örnekler ve diğer metalik
örneklerle polimerik örnekler 48 saat inkübasyonda yüksek hücre canlõlõğõ oranlarõ
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göstermişlerdir. 72 saatten sonra, büyük olasõlõkla ortama salõnan iyon ve partiküllerden
dolayõ hücre canlõlõğõnda bir azalma tespit edilmiştir. Özellikle 48 ve 72 saat
inkübasyonlardan sonra, artan ekstrakt konsantrasyonu ile azalan oranda hücre canlõlõğõ
arasõnda bir korelasyon gözlemlenmiştir.
Periferik kan mononüklear hücrelerinden sitokin salgõlanmasõ analizlerine göre
HA 800 °C, HA-Alumina 1250 °C and HA-Zirkonya 1250 °C peletleri IL-1α
salgõlanmasõnda azalmaya neden olmuş, diğer yandan LPS ile tetiklenmiş hücrelerde
BSA ile kaplanmõş HA 1250 °C, alumina 1450 °C ve zirkonya 1450 °C peletleri kontrol
kültürlerine ve BSA ile kaplanmõş HA 800 °C peletlerine nazaran yüksek oranda IL-1α
salgõlanmasõna yol açmõşlardõr. Paslanmaz çelik, titanyum alaşõmõ ve cirulene
örneklerinde düşük oranlarda IL-1α tespit edilmiştir. BSA ile kaplanmõş HA 800 °C
peletleri kaplanmamõş HA 800 °C peletlerine oranla daha yüksek miktarda IL-6
salgõlanmasõna neden olmuşlardõr. Metalik örneklerle inkübe edilen hücrelerde (LPS
varlõğõnda ve yokluğunda) düşük seviyede IL-6 salgõlanmasõ tespit edilmiştir.
Mononüklear hücrelerin biyomalzemelerin varlõğõnda çoğalmalarõ ve
aktivasyonu incelenmiştir. Con A ile tetiklenen mononüklear hücrelerin çoğalmasõ
üzerinde HA 800 °C, HA-Alumina 1250 °C ve HA-Zirkonya 1250 °C örneklerinin
inhibisyon etkileri olduğu belirlenmiştir. Mononüklear hücrelerin aktivasyonunda HA
800 °C ve HA 900 °C örnekleri bütün inkübasyon sürelerinde en düşük seviyede
aktivasyona neden olmuşlardõr. Bunun yanõ sõra, diğer seramik örnekler de 48 ve 72 saat
inkübasyonlarda kontrollerden daha düşük oranda hücre aktivasyonu göstermişlerdir.
Sadece 24 saatte ve düşük konsantrasyonlarda seramik ekstraktlarõ hücreleri aktive
etmişlerdir.
Çalõşmamõzda seramik örneklerin çözünürlük özellikleri belirlenmiştir. Sadece
HA 800 °C peletleri hücre besiyerinin ve deiyonize suyun elektriksel iletkenliğinde
yükselmeye neden olmuştur. Ayrõca, diğer örneklerde görülmemesine rağmen, HA 800
°C peletlerinin varlõğõnda hücre besiyerinin ve deiyonize suyun pH değerlerinde az
oranda yükselme tespit edilmiştir.
Biyomalzemelerin PBS içerisindeki ekstraksiyonlarõnda Salmonella
typhimurium TA100 suşu üzerinde herhangi bir mutajenik etki mutajen madde (sodyum
azid) ve negatif kontrol ile karşõlaştõrõldõğõnda gözlemlenmemiştir. Ayrõca, seramik,
metalik ve polimerik örneklerin hem toz hem de pelet formlarõnõn gram-negatif suşlar
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(E. coli, P. aeruginosa, K. pneumonia, Proteus spp.) ve gram-pozitif suşlar (S. aureus
and S. pyogenes) üzerinde herhangi bir anti-bakteriyel etkisi bulunmamõştõr. Bakteri
adezyonu çalõşmalarõnda yüzey pürüzlülüğünün ve diğer yüzey özelliklerinin
bakterilerin bağlanmasõ, adezyonu ve biyofilm oluşturmalarõnda önemli roller oynadõğõ
sonucuna varõlmõştõr. Sonuç olarak, düşük sõcaklõkta sinterlenmiş örnekler hücre
canlõlõğõnda azalmaya neden olmasõna rağmen bütün test edilen malzemeler vücut
dõşõndaki biyouyumluluk değerlendirmeleri için pozitif sonuçlar vermişlerdir.
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1Chapter 1
INTRODUCTION
The use of natural biomaterials dates back to antique times. Hair, cotton, animal
sinew, tree bark and leather of animals have been used as natural suture materials for
almost 4000 years. Plates made up with gold were used for skull repair in 1000 B.C.,
and gold-wire sutures as early as 1550 [1]. Today, almost nobody exists without one or
more biomaterials in his/her body. Dental filling materials, hip prosthesis, cardiac
pacemakers, catheters, kidney dialysers, vascular grafts, eyeglasses and lenses are some
examples of biomaterials. Ceramic, metallic, polymeric and composite materials
produced by high technology are used in order to improve or treat human health and to
increase welfare of the society. One of the important advantages of biomaterials to the
society is to increase survival rate through the end of 20th century. In fact, after age of
30, human body starts to deteriote, connective tissues begin to decrease, volume of
bones and their strength decrease and the probability of fracture increases [2]. In this
point, the importance of biomaterials is inevitable. Not only older members of society
but also the young need biomaterials for more effectiveness and welfare in their old
ages. Therefore, production of new materials with optimum physical strength and
biocompatibility has being the subject of many studies.
Newly synthesized or produced biomaterials have to be tested for their physical,
chemical and mechanical properties. Desired biological responses and performance of
biomaterials should be examined by in vitro and in vivo tests first. Afterward, the
evaluation has to be concluded with clinical trials. An ideal biomaterial does not cause
inflammation, undesired immunological responses, cancer, cytotoxicity and
mutagenicity. During implantation of biomaterials, they contact with blood especially
mononuclear cells having roles in the immunological responses and inflammation.
Therefore, the purpose of this study was to examine the effects of ceramic, metallic and
polymeric biomaterials and their extracts with different surface properties on the
viability, proliferation, activation of peripheral blood mononuclear cells (PBMC) and
the release of inflammatory cytokines IL-1α and IL-6 from PBMC. In addition, the
mutagenic potential of extracts of biomaterials, anti-bacterial effects and adhesion of
2pathogenic bacteria to the surface of biomaterials were investigated. Finally, the
dissolution properties of ceramic pellets especially at low and high sintered
temperatures were studied on the basis of conductivity and pH alterations in different
solutions.
3Chapter 2
BIOMATERIALS AND BIOCOMPATIBILITY
2. 1. Biomaterials
A biomaterial is a non-viable material that interacts with biological systems
which is used in the production of a medical device [3]. As a field of study, biomaterials
combine different disciplines. As a material science, biomaterials are related with the
physical properties, chemical compositions and structures. As an interdisciplinary
science, biomaterials are considered the interactions between living and non-living
materials. As a medical science, their goal is the improvement of the human health and
quality of life [4]. Some of the commonly used biomaterials are explained in Table 2.1.
According to biological responses, biomaterials can be classified as biotolerant, e.g.
bone cement, stainless steel, and cobalt-chrome alloy; bioinert, e.g. alumina, zirconia,
carbon materials and titanium; and bioactive materials, e.g. calcium phosphate ceramics,
hydroxyapatite (HA), and glass ceramics. Between a biotolerant material and
surrounding bone a connective tissue layer is observed. In fact, tissue encapsulates these
inert materials in fibrous tissue. A direct contact between implant material and
surrounding bone is observed in bioinert materials and a stable oxide layer on the
surface is the main characteristic of bioinert materials. A direct chemical bond is formed
in bioactive materials between implant and surrounding bone [5]. Chemical composition
and structure of biomaterials is the main reference for the production of medical
devices. Ceramics, metals, polymers and composite materials are classified on the basis
of their chemical composition.
4Table 2.1. Examples of biomaterials applications [6]
Cardiovascular implants Heart and valves
Vascular grafts
Pacemakers
Stents
Plastic and reconstructive implants Breast augmentation or
reconstruction
Maxillofacial reconstruction
Penile implant
Orthopedic prostheses Knee joint
Hip joint
Fracture fixation
Opthalmic systems Contact lenses
Intraocular lenses
Dental implants
Neural implants Hydrocephalus shunt
Cochlear implant
Extracorporeal Oxygenators
Dialyzers
Plasmapheresis
Catheters
Devices for controlled drug
delivery
Coatings for tablets or
capsules
Transdermal systems
Microcapsules
Implants
General surgery Sutures
Staples
Adhesives
Blood substitutes
Diagnostics Fiber optics for endoscopy
52. 1. 1. Ceramics
Specially designed ceramic materials, in other words, bioceramics have being
used for the repair, reconstruction, and replacement of diseased or damaged parts of the
body since 1960s. Polycrystalline (Alumina or HA), bioactive glass, bioactive glass-
ceramic or bioactive composite (Polyethylene-HA) are the main examples of
bioceramics. Principal characteristics of bio-inert ceramics are wear resistance, minimal
biological response, stiffness, strength and toughness especially in total joint
replacements. Bioactive ceramics have porous and crystalline structures and they are
also biocompatible. However, ceramic materials are brittle, difficult to produce and they
have no resilience properties. In fact, low tensile strength and fracture toughness limit
the usage of bioactive ceramics [7].
The ingrowth of tissues into pores of ceramic materials on the surface or
throughout the material takes place. The increased interfacial area between the implant
and surrounding tissue causes an increase in the resistance to the movement of device
[5]. The growth of tissue into pores of ceramic material is termed biological fixation.
For the viability of tissues in the pores, the size of pores must be >100-150 µm in
diameter. This large interfacial area is essential for blood supply of connective tissue. In
the pores with <100 µm in diameter, no vascular tissue was observed. In some cases
micromovement takes place at the interface of a porous implant that results in damage
to the tissue. The tissue dies, inflammation ensues and the interfacial stability can be
destroyed. Types of bioceramic tissue attachment mechanisms are explained in Table
2.2.
Surface activity of bioactive ceramics especially bioactive glasses and HA is
responsible for the formation of the interfacial bond. The formation of a
hydroxycarbonate apatite (HCA) surface layer is another characteristics of bioactive
ceramics. The first stage in surface reactivity of bioactive glasses is the loss of sodium
ions from the surface of the glass via ion exchange with hydrogen (H+ or H3O+). The
reaction takes place rapidly, within minutes of material exposure to body fluids. A
dealkalinization of the surface layer with a negative charge is created. The removal of
sodium ions through aqueous environment results in a localized breakdown of the silica
network with the resultant formation of silanol (Si(OH)4) groups. After that,
repolymerization into silica-rich surface layer occurs. This surface layer is highly
porous with average pore diameter of 30-50 Å.
6Table 2.2. Types of bioceramic tissue attachments [5]
Type of attachment Type of bioceramic
Dense, nonporous, almost inert ceramics attach by bone
growth into surface irregularities by cementing the device
into the tissue, or by press-fitting into a defect
(morphological fixation).
Al2O3
ZrO2
For porous implants, bone ingrowth occurs, which
mechanically attaches the bone to the material
(biological fixation).
Porous HA
HA-coated porous metals
Surface reactive ceramics, glasses, and glass-ceramics
attach directly by chemical bonding with the bone
(bioactive fixation).
Bioactive glasses
Bioactive glass-ceramics
Dense HA
Resorbable ceramics and glasses in bulk or powder form
designed to be slowly replaced by bone.
Calcium sulfate
Tricalcium phosphate
Calcium phosphate salts
Bioactive glasses
It was proposed that the loss of soluble silica from the surface of bioactive glasses might
be at least partially responsible for stimulating the proliferation of bone-forming cells
on the glass surface. After the formation of the silica-rich surface layer, an amorphous
calcium phosphate layer is formed on the glass surface and incorporation of biological
molecules, for example, blood proteins, growth factors and collagen takes place.
Adsorption of biological molecules occurs beginning from the surface reactions. Within
3 to 6 hours in vitro, calcium phosphate layer crystallize into hydroxycarbonate apatite
layer that is the bonding layer. This surface, which is structurally and chemically similar
to bone mineral and tissues in the body can attach to this layer directly. The reactivity
goes on with time and HCA layer grows in thickness for the formation of a bonding
zone with approximately 100-150 µm. This layer is mechanically compliant interface to
maintain the bioactive bonding of the implant material to natural tissue. These surface
reactions take place within the first 12 to 24 hours of implantation. Osteogenic cells,
such as osteoblasts or mesenchymal stem cells, infiltrate a bony defect in 24-72 hours.
Cells encounter a bonelike surface that is not foreign for cells. At the end of these
sequential reactions, a direct bond of the material to tissue was produced. Bioactive
glasses minimize the actions of macrophages and inflammatory responses [8].
In addition to biological response of bioceramics, mechanical and physical
properties are crucial for their performance in the body (Table 2.3). Bioceramics have
been used in non-load bearing parts of the body. In the restoration of middle ear, HA in
7a combination of porous and dense forms has been used successfully. Moreover, HA
has been applied onto mechanically stronger materials as a coating. HA coating was
carried out on porous stainless steel as a tooth replacement. HA coating allows bone to
be incorporated within the porous metal [9].
Table 2.3. Physical and mechanical properties of bioceramics [5,7]
Material Porosity
(%)
Density
(mg/m3)
Young’s
Modulus
(GPa)
Compressive
Strength
(MPa)
Tensile
Strength
(MPa)
Flexural
Strength
(MPa)
Bioactive
ceramics and
glass ceramics
-
-
31-76
-
2.8
0.65-1.86
-
-
2.2-21.8
-
500
-
56-83
-
-
-
100-150
4-35
Hydroxyapatite 0.1-3
10
30
40
2.8-19.4
2.5-26.5
3.05-3.15
2.7
-
-
2.55-3.07
-
7-13
-
-
-
44-48
55-110
350-450
-
120-170
60-120
310-510
≤ 800
38-48
-
-
-
-
-
100-120
-
-
15-35
60-115
50-115
Tetracalcium-
phosphate
Dense 3.1 - 120-200 - -
Tricalcium-
phosphate
Dense 3.14
-
-
-
120
7-21
-
5
-
-
Al2O3 0
25
35
50-75
3.93-3.95
2.8-3.0
-
-
380-400
150
-
-
4000-5000
500
200
80
350
-
-
-
400-560
70
55
6-11.4
ZrO2,
stabilized
0
1.5
5
28
4.9-5.56
5.75
-
3.9-4.1
150-190
210-240
150-200
-
1750
-
-
< 400
-
-
-
-
150-700
280-450
50-500
50-65
Cortical bone - 1.6-2.1
(g/cm3)
7-30 100-230
Cancellous
bone
- - 0.05-0.5 2-12 - -
82. 1. 2. Metals
Metallic implants possess the property of being able to endure tensile stresses.
Metals are mainly used in load bearing parts of the body. Typical examples of highly
loaded implants are hip and knee endoprostheses, plates, screws, nails and dental
implants. In addition, metallic biomaterials are applied to unloaded and functional
devices such as cages for pumps, valves and heart pacemakers, conducting wires,
etc.[10]. Generally, metals are characterized with toughness and ductility (Table 2.4).
On the other hand, the main drawbacks of these materials are corrosion and density. The
corrosion process of a metal implant produces a flow of electrons and ions through the
surrounding tissue. This flow may affect the physiological ion movement of the nerve
cells. An inorganic reaction of corrosion products is caused by the solution of metal ions
in the body fluid. These products are transported into various organs where they are
concentrated and lead to systemic or hypersensitive responses if the limit of toxicity for
a certain metal is exceeded [10].
Table 2.4. Mechanical properties of metallic biomaterials [11]
Metal Alloys Modulus (GPa) Tensile Strength (MPa)
Stainless steel 190 586
Co-Cr alloy 210 1085
Titanium alloy 116 965
Amalgam 30 58
The most commonly used metallic biomaterials in orthopedics are stainless steel,
cobalt based super-alloys, titanium and titanium based alloy systems. Stainless steel
(20% chromium, 17% nickel) mostly 316L has appropriate mechanical properties for
the production of medical devices. Cobalt-chrome alloys (30% chromium, 70% cobalt)
are the most corrosion and fatigue resistant implant alloys. Commercially pure (c.p.)
titanium is characterized with high corrosion resistance and biocompatibility. Elastic
modulus of titanium is closer to cortical bone as compared to other metallic implant
materials. Titanium alloy (Ti-6Al-4V) has superior mechanical properties with the same
corrosion resistance and elastic modulus of c.p. titanium [12]. Titanium is rapidly
oxidized when exposed to oxygen and this oxide layer minimizes the corrosion of
9titanium and allows for the attachment of biological molecules in physiological
environments. Serum proteins can adsorb to the surface oxide and produce a protein
layer. Some of these proteins serve as ligands for the receptors of cell membrane.
Appropriate interactions of ligand-receptor complexes lead to signals for intracellular
chemical reactions and consequently cell functions such as adhesion and differentiation
of cells on the material surface [13]. In addition to protein adsorption, significant
changes take place on the surface of material. Oxidation of metallic samples was
described both in vivo and in vitro systems [14,15]. Although metallic materials have a
stable oxide layer, they undergo electrochemical changes in the physiological
environments. Depending on the type of sterilization, c.p. titanium implants have an
oxide thickness of 2-6 nm before implantation [16]. Films on implants removed from
human tissues are 2-3 times thicker [14,16,17]. Moreover, the chemical composition of
oxide layer changes by incorporating Ca, P, and S [16,17].
Metallic materials are coated with films and other materials to increase their
biocompatibility. Diamond-like carbon (DLC) coatings did not result in toxicity toward
living cells, inflammatory response or loss of cell integrity and any cellular damage
[18]. Ceramic materials especially HA are suitable porous coating materials on the
surface of metals for tissue ingrowth [12,19]. Furthermore, the molecules with known
biological activity such as alkaline phosphatase or albumin were covalently linked to
oxidized titanium surfaces to improve integration of implants to the host tissues [20].
2. 1. 3. Polymers
Polymers are used mainly in tissue engineering, implantation of medical
devices, production of artificial organs and prostheses, ophthalmology, dentistry, repair
of bones and drug delivery systems. Polymethylmethacrylate (PMMA), polyethylene
(PE), polypropylene (PP), polytetrafluoroethylene (PTFE) and Teflon are some
examples of polymers used in the medical applications (Figure 2.1). The main
advantages of polymers are elasticity and easiness in the production. Whereas,
mechanical properties and some deformation-degradation problems have been observed
in the medical applications. The mechanical properties of commonly used polymers in
the medical applications are described in Table 2.5.
Polymeric materials must be biocompatible at least on the surface. Many
polymeric systems used as biomaterials were rejected by the body and were isolated
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after implantation with collagenous encapsulation. However, due to encapsulation of
biofilm generated on the surface, materials do not induce any harmful effects.
Moreover, a thrombus formation is seen when polymers contact with blood cells. In this
respect, polymers with non-thrombogenic blood compatible surfaces are used to interact
directly with blood stream [21]. Expanded polytetrafluoroethylene (ePTFE) or woven
Dacron used as vascular grafts inert to white blood cell activation and thrombogenicity
[22]. Functional groups on surface are responsible for biocompatibility, biodegradation
and other therapeutic actions.
Table 2.5. Mechanical properties of polymeric biomaterials [11]
Material Modulus (GPa) Tensile Strength (MPa)
Polyethylene (PE) 0.88 35
Polyurethane (PU) 0.02 35
Polytetrafluoroethylene (PTFE) 0.5 27.5
Polyacetal (PA) 2.1 67
Polymethylmethacrylate (PMMA) 2.55 59
Polyethylene terepthalate (PET) 2.85 61
Polyetheretherketone (PEEK) 8.3 139
Silicone rubber (SR) 0.008 7.6
Polysulfone (PS) 2.65 75
Biodegradable polymers also called bioerodible or bioresorbable are produced
from synthetic or natural origins. As a result of hydrolysis, the body eliminates non-
toxic alcohols, acids and other low molecular weight products. High molecular weight
polymers with hydrolytically unstable crosslinks may be degraded through crosslinked
chains. Water insoluble polymers may be converted into water soluble ones because of
ionization, protonation or hydrolysis of side chains. These events do not affect the
molecular weight of materials, but in the topical applications they may be responsible
for bioerosion [21].
Implantation of a non-biological material leads to an interaction with proteins in
the body fluids. Mainly, adsorption of proteins to polymer surfaces is responsible for
cell-biomaterial interactions [23]. Coating of polymers with albumin, high-density
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lipoprotein and immunoglobulin G inhibited the adhesion of endothelial cells. On the
contrary, fibronectin coating onto polyethyleneterephthalate, fluoroethylenepropylene
copolymer and Teflon promoted the cell adhesion [24].
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Figure 2.1. Various applications of polymer composite biomaterials in the human
body [11].
2. 1. 4. Composites
Composite materials are made from two or more materials to obtain stronger,
tougher, stiffer and long lasting materials. Mechanical properties of composite materials
depend on the properties of both phases (matrix and strengthening phase or phases) as
well as on the nature of phase interfaces, their volume fractions, and the local and global
arrangement of the reinforcing phase(s) [25]. For example, ceramic-polymer composites
(HA-Polyethylene) are used for the production of bone analogue rather than in load
bearing bone implants. The main drawback of these materials is the difficulty in
production. Composites are mostly used in dentistry.
2. 2. Tissue-Biomaterial Interactions
The tissue-biomaterial interface is established on implantation process that lead
to contact of implant materials with blood. These initial events are taken place by the
adsorption of proteins from the blood onto the surface of materials. At least three
different driving forces play a role in the adsorption of proteins onto polymer surfaces
according to previous work. Firstly, thermodynamically either enthalpy or entropy
changes may be sufficient to provide negative free energy change for protein adsorption
under physiological conditions. Secondly, the ambivalent polar/non-polar characteristics
of proteins favour a concentration of proteins at interfaces; and thirdly, adsorption of
proteins increases as the solubility decreases [26]. The nature of implanted material or
device, including surface chemistry, surface morphology, net charge, porosity and
degradation rate are important for tissue-biomaterial interactions [27]. Adsorption of
proteins and other biologically active molecules onto implant materials with appropriate
interactions is followed by attachment and proliferation of cells. In the case of bone
implants, following the implantation a sequence of events take place including the
development of vascularized granulation tissue and collagenous materials (fibrous
callus), deposition of non-mineralized bone matrix, deposition of mineralized bone
around bone cells and matrix (bony callus) and, finally, remodeling of woven bone to
lamellar bone (Figure 2.2). Tissue ingrowth of mesenchymal cells (fibroblasts,
endothelial cells and bone cells) occur through the implanted material which are
especially porous material implants and bone cements [28].
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Figure 2.2. Sequential events in the bone-implant interface. (a) Protein adsorption
from blood and tissue fluids, (b) protein desorption, (c) surface changes and
material release, (d) movement of inflammatory and connective tissue cells
through the implant, (e) release of matrix proteins and selected adsorption of
proteins such as noncollagenous proteins (bone sialoprotein and osteopontin), (f)
formation of lamina limitans and adhesion of osteogenic cells, (g) bone deposition
on both the exposed bone and the implant surfaces, (h) remodelling of newly
formed bone [29].
2. 3. Biocompatibility
Biocompatibility can be defined as the ability of a material to perform with an
appropriate host response in a specific application [30]. Tissue compatibility and blood
compatibility constitute biocompatibility of a test material. Ideally, a blood compatible
material does not lead to thrombosis (formation of a solid mass from the molecular and
cellular constituent of blood), destruction of cellular components, alteration of plasma
proteins and enzymes. Tissue compatible material does not cause undesired immune
responses, inflammation, mutation, cancer, and toxic reactions in the body [31].
2. 3. 1. The Inflammatory Responses
Most of the biomaterials are believed that they are inert, non-toxic and non-
immunogenic. However, most of implants prompt acute inflammatory responses in the
host and the main characteristic of this response is the accumulation of phagocytes on
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implant surfaces. Pain, redness, heat and swelling at the site of infection or physical
injury are the major features of inflammatory response. The magnitude of these effects
depends on the intensity and extent of inflammatory process. The presence of an
implant does not lead to additional signs or symptoms, but may alter their severity and
duration [32]. The size, shape, chemical and physical properties of biomaterials may be
responsible for severity and duration of inflammation and wound healing processes. In
the inflammatory response, predominant cell types depend on the age of injury, i.e., the
time since the implant was inserted. During the first several days following the
implantation, neutrophils are predominant cell type of acute inflammation. Then,
neutrophils are replaced by monocytes as the predominant cell type. According to the
extent of injury, acute inflammation occurs in minutes to days. Acute inflammation is
characterized with the exudation of fluid and plasma proteins (edema) and the
immigration of leukocytes (predominantly neutrophils) [33]. Localization of leukocytes
at the site of implant material causes phagocytosis, release of enzymes and reactive
oxygen intermediates and other agents by the activation of neutrophils and
macrophages. Phagocytosis takes place when the cell membrane interacts with a foreign
material, which is either inorganic or organic. In fact, chemical composition, local pH
differences and electrochemical factors associated with foreign material affect attraction
of neutrophils. The released hydrogen ions, enzymes, reactive oxygen intermediates and
other agents affect the biodegradation of biomaterials [34,35]. Ions or particles such as
cobalt, chromium and nickel are released from metallic alloys into tissue around the
implant. These particles can activate neutrophils and release of lysozyme from these
cells. Furthermore, if implant material is toxic for tissue, it leads to death and lysis of
cells. Recent studies showed that ceramic powders, such as HA, stimulate neutrophils to
secrete lysosomal enzymes that digest proteins on the surface of ceramic powders. In
addition, stimulated neutrophils phagocytose the ceramic powders in vivo [36].
Frequently, acute inflammatory responses are followed by chronic inflammation.
Furthermore, fibrosis around implants is observed. Chronic inflammation causes the
degradation and failure of many types of implants, such as pacemaker leads, mammary
prosthesis and joint implants. In fact, accumulation of host proteins and adsorption of
fibrinogen play important roles in the induction of inflammation [37].
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2. 3. 2. The Immunological Responses
A biomaterial is a foreign substance to the body; therefore, it is not surprising
that it may cause the production of immune cells, mediator molecules and proteins in
the biomaterial applications. Inflammatory responses are the first line of defence
mechanism. The second line of defence possesses both specificity and memory that is
called the immunological response. Only certain types of materials result in an immune
response and extent of this response depends on the nature of materials. The memory is
developed when the materials are first applied. This recognition pattern is brought into
play when the tissues are exposed a second or subsequent times. Most of biomaterials
are non-antigenic. However, biomaterials may activate the immune responses due to
binding of products with some appropriate carrier molecules in the tissues. The humoral
response of the body against biomaterials occurs via production of antibodies to bind
and inactivate foreign bodies and antigens. In the cell-mediated response, especially
lymphocytes are able to recognize invaders with receptors to kill or inactivate in the
body [26].
 Complement activation system containing 13 serum proteins is a part of the
immune response and plays an important role in acute inflammation. Mainly C3a, C5a
and C3b proteins of complement system result in alterations in vascular permeability,
histamine release from mast cells, activation of leukocytes and phagocytosis of
pathogens. C3a and C5a activate monocytes and macrophages to secrete interleukin-1
(IL-1) that has an ability to stimulate the proliferation of fibroblasts and pyrogenic
activity [36]. In rats, inflammation can be observed due to activation of complement
after intramuscular implantation of cobalt and nickel discs [38]. Ceramic powders such
as CaHPO4, Ca3(PO4)2 and coral can trigger complement system due to resorption of
ceramic implants. The interaction of blood and biomaterial involves adsorption of
plasma proteins that mediates cellular adhesion. Surface of macrophages has receptor
molecules for C3b. These receptors lead to the cells to adhere to other cells or
biomaterial surfaces bearing C3b. Adhesion of phagocytic cells on the surface of
biomaterials causes release of degradative enzymes and high-energy oxygen species.
Phagocytosis of both HA and β-whitlockite by macrophages results in resorption of
ceramic biomaterials [36].
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2. 3. 3. Tumour Induction by Biomaterials
Tumours are the result of excessive and uncontrolled proliferation of cells.
Benign tumours are localized to their site of origin. On the other hand, malignant
tumours are able to spread other organs and tissues via the body fluids. In addition to
the chemical composition of biomaterials, physical factors play roles in the formation of
tumours. Tumour induction properties of biomaterials were tested in the laboratory
animals. Examples of polymeric, metallic, ceramic and mineral materials have been
shown to be carcinogenic under some conditions in the experimental animals, especially
rodents [39]. The size of implant material is important for the tumour formation in the
case of polymeric implants. Large monolithic materials tend to be most effective agents,
whereas small particles are generally less active tumourigenic agents. However, in
metallic implants, small particles with enhanced surface area are able to act as a source
of ions. In fact, metal ions such as nickel are known to be potential chemical
carcinogens; therefore, chemical composition dominates particle size effects in metals
[26].
2. 3. 4. Cytokine Secretion From Cells
Cytokines are soluble proteins that regulate proliferation, differentiation and
functions of many kinds of cells. Cytokine producing cells and target cells form a
complex cellular network and signalling within the immune system. Low concentrations
(nano or picomolar) of cytokines act very effective. Growth factors, colony stimulating
factors, interleukins, lymphokines, monokines and interferons are described as
cytokines. In the inflammatory responses of body, cytokines such as IL-1, IL-6 and
TNF-α play important roles.
2. 3. 4. 1. Interleukin-1α
IL-1 consists of IL-1α and IL-1β types. The cells of healthy individuals do not
secrete IL-1 with the exception of skin keratinocytes, some epithelial cells and certain
cells of the central nervous system. In the stimulus of inflammatory agents, infections
and microbial endotoxins, an increase in the production of IL-1 by macrophages and
other cell types has been observed [40,41]. IL-1 plays important roles in the immune
functions. IL-1 has effects on macrophages/monocytes, T lymphocytes, B lymphocytes,
and Natural Killer Cells. IL-1 activates secretion of other cytokines, e.g. IL-6 and
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Tumor Necrosis Factor (TNF) [42,43]. Moreover, induction of fever and increasing the
levels of C Reactive Protein expression, production of inflammatory responses and
prostaglandin are some biological responses of IL-1.
Secretion of IL-1 in the presence of some biomedical polymers (polyethylene,
silica-free polydimethylsiloxane (PDMS), woven Dacron fabric, ePTFE and segmented
polyurethane (Biomer)) was examined. Statistically significant differences were
obtained between tested polymeric materials. High secretions of IL-1 from monocytes
in Dacron and PE, intermediate secretion in ePTFE and low secretions in Biomer and
PDMS were obtained [44].
2. 3. 4. 2. Interleukin-6
IL-6, a multifunctional protein, produced by lymphoid and non-lymphoid cells,
normal and transformed cells, including T cells, monocytes/macrophages, fibroblasts,
hepatocytes, vascular endothelial cells, cardiac myxomas, bladder cell carcinomas,
myelomas, astrogliomas and glioblastomas. Secretion of IL-6 from these cells are
regulated either positively or negatively by mitogens, antigenic stimulation,
lipopolysaccharides (LPS), IL-1, TNF, platelet derived growth factor and viruses [45-
47]. IL-6 has several biological functions on the cells. For example, it stimulates
differentiation and secretion of antibodies on B cells [48-52]; IL-2 production and IL-2
receptor expression on T cells. Furthermore, IL-6 shows a growth factor activity for
mature thymic or peripheral T-cells and stimulates differentiation of cytotoxic T-cells in
the presence of IL-2 or interferon-γ [53-55]. In addition to described roles of IL-6, it has
a major role in the mediation of inflammatory and immune responses initiated by an
infection or injury.
Proinflammatory effects of some metals have been reported. For example, test
specimens fabricated from copper, nickel, zinc, cobalt, palladium, tin, indium, a high
noble cast alloy and a dental ceramic gave rise to significant increase in IL-6 levels in
fibroblast-keratinocyte cultures [56]. Woven Dacron used as a vascular graft induced
significantly higher levels of IL-6 and TNF-α from white blood cells compared to
another vascular graft material, ePTFE [57].
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2. 3. 5. Blood Compatibility
The evaluation of blood compatibility has been gained importance by the
widespread use of cardiovascular devices and grafts. Catheters, cannulae, guide wires,
stents, shunts, heart valves, heart and ventricular assist devices, oxygenators, and
dialysers are commonly used devices. The variables influencing blood-biomaterial
interactions are explained in Table 2.6. Some events can lead to serious clinical
complications in the body. These complications include: (1) thrombosis, (2)
thromboembolism, (3) consumption (ongoing destruction) or activation of circulating
blood elements, and (4) activation of inflammatory and immunologic pathways.
Thrombus forms as the localized accumulation of blood elements on, within, associated
with a vascular device. Formation of thrombus results in device dysfunction or blood
vessel occlusion. Interruption of normal blood flow may cause ischemia (relative lack of
oxygen) and infarction (tissue death due to total oxygen deprivation) in distal
circulatory beds leading to heart attacks and strokes. Blood clots are relatively
homogenous containing red blood cells and platelets trapped in a mesh of polymerised
protein (fibrin). However, thrombus composed of layers of fibrin and platelets can be
formed under arterial flow conditions and high fluid shear rates. Thromboembolism is
the blocking vessel by a thrombus in the blood flow. Thromboembolism is the common
cause of stroke (cerebrovascular infarction) and peripheral limb ischemia [58]. When an
artificial surface interacts with blood, it causes platelet adhesion and aggregation in the
body. Adsorption of gamma globulin and fibrinogen on the surface of materials increase
platelet adhesion, but this adhesion is reduced by albumin. Incomplete
heterosaccharides of these proteins and glycosyl transferases on the platelet membrane
constitute the adsorption mechanism on the surface. In fact, the absence of such
saccharide chains in albumin structure leads to its inhibitory effect [31].
19
Table 2.6. Variables influencing blood-biomaterial interactions [58]
Device Properties Size and shape
Surface composition
Texture and roughness
Mechanical properties
Blood Flow Phenomena Shear factors
Convection and diffusion of reactants, products,
cofactors and inhibitors
Disturbed flow and turbulence
Blood-Chemistry Related Effects Coagulation status
Antithrombotic and other therapies
Contrast media
Other Variables Duration of device blood exposure
Tissue injury
Infection
2. 4. In vitro Biocompatibility Tests
In vitro biocompatibility tests were developed to simulate and anticipate
biological reactions to implant materials in the host when operated into or on tissues
[59]. Some of the in vitro tests are described below.
2. 4. 1. The Viability of Cells
The viability of cells is a crucial parameter for biocompatibility of materials that
is determined by staining cells with neutral red, trypan blue, amido black or propidium
iodide (PI) after incubation of cells with test materials in the optimum cell culture
conditions. The lysosomes of viable cells engulf neutral red and these cells stained red.
Cellular proteins within non-viable cells take up trypan blue and dead cells appear as
blue under light microscope. Live and dead cells are counted and proportion of the cells
gives the percent cell viability. In another method, after fixation of cells, amido black
weakly binds to cell proteins and dye can be extracted from cells by alkaline treatment.
By measuring the optical density of released neutral red, trypan blue or amido black by
a spectrophotometer, a reliable index of the number of viable cells in the sample is
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obtained. In addition to vital dyes, PI stains the necrotic cells with destructed cell
membranes by toxic materials. PI intercalates with double stranded DNA and/or RNA
in these cells and the proportion of dead cells can be quantified by flow cytometric
analysis [60]. The effects of alkyl-2-cyanoacrylate esters which are used as adhesive
materials with good mechanical properties on L 929 mouse fibroblasts were examined
by neutral red and trypan blue staining. The tested cyanoacrylate adhesive materials
were found to be cytotoxic and to inhibit cell proliferation [61].
2. 4. 2. The Cytotoxicity of Materials
Cytotoxicity is the evaluation of toxic effects of materials using cell culture in
vitro. Cytotoxicity assays measure only limited effects on cells during the first 12-24
hours after being exposed to toxic substances. The host cells either recover from or
accept their chemical injury. However, many biological reactions are not simply as in
vitro cytotoxicity [59]. Toxic or undesired effects such as inflammation and immune
reactions can be seen in long period of time. In vitro cytotoxicity tests are used to
determine the response of cells in the culture by direct contact with devices or with their
extracts in DMSO, physiological saline or cell culture medium. The toxicity is assayed
by loss of cell viability. MTT assay was used for the quantitation of lymphokines, cell
mediated cytotoxicity, cell chemosensitivity testing of anti-tumour agents and generally
for cell growth and activation. Recently, the assay was applied for the determination of
cytotoxicity of biomaterials in in vitro tissue culture systems. MTT assay is a rapid and
sensitive colorimetric assay. The assay is an alternative method to the conventional 3H-
thymidine uptake and other assays for measurement of cell viability and proliferation.
MTT assay is based on the capacity of the mitochondrial dehydrogenase enzymes to
convert a yellow-water soluble tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) into a purple insoluble formazan product by a
reduction reaction. The insoluble crystals are dissolved in DMSO or acidic isopropanol
for the measurement of absorbance values in a spectrophotometer. Active mitochondrial
dehydrogenases of living cells can cause conversion of the dye. Dead cells do not lead
to this change [62-65]. The biocompatibility of cast non-alloyed titanium and castable
alloys were examined by using human primary oral fibroblasts. All tested metallic
materials showed cytotoxic properties on primary cultures on the basis of MTT assay
[66].
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2. 4. 3. The Mutagenicity of Materials
The mutagenicity tests show the ability of a material to induce mutation or
chromosomal damage and tumour formation. Mutation is inheritable genetic change that
occurs either in genes or in chromosome number or structure. In in vitro mutagenicity
tests, prokaryotic organisms are mostly used due to their simple genetic structure [67].
AMES test is a sensitive, rapid and accurate method for the identification of mutagens.
The test is based on histidine dependence and mutations in Salmonella typhimurium
strains TA97a, TA98, TA100, TA102 and TA1535. The Salmonella reverse mutation
test is carried out by mixing test sample with Salmonella strains in a soft agar solution
containing only small amounts of histidine that permits the bacteria to undergo a limited
number of divisions, but it is not sufficient for normal growth of the bacteria. If the
strain undergoes a reverse mutation in the histidine gene induced by test substance or
material, the bacteria do not require histidine anymore to grow and they can be observed
as visible colonies. In addition, a spot test is performed by spotting test substance on a
plate containing the bacteria with a small amount of histidine. Mutagenicity of test
substance is determined by the inhibition of bacterial growth on the plate that is the
result of diffusion of test substance through agar. The tests are carried out both with and
without S-9 activation, which is used to simulate mammalian liver enzyme systems. The
purpose is to detect substances undergoing metabolic activation from non-mutagenic
forms [68]. Moreover, detection of mutagens on the basis of specific mutations in
tryptophan operon is carried out with WP2 strain of E. coli [67].
 In addition to AMES and E. coli tests, there are other mutagenicity tests. One of
them is mouse lymphoma test. In this test procedure, cells containing the enzyme
thymidine kinase (TK) are susceptible to a toxic effect of trifluorothymidine (TFT),
which is metabolized in a false metabolite incorporated in DNA and RNA. The cells
with mutated TK gene cannot form the false metabolite. These cells can survive in the
presence of TFT [67]. The other mutagenicity test is quantitative mammalian cell gene
mutation assay. Mutations are detected at hprt locus in the genome of V79 fibroblasts of
Chinese hamster. V79 fibroblasts are grown at optimum conditions and each day cell
number is determined for acute toxicity of materials. After 10 days subculturing, cells
are replated in a selective medium containing 6-thioguanine in order to isolate mutated
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cells. The cell colonies are stained with methylene blue and mutation frequency is
calculated [69].
Mutagenic effects of various dentin bonding agents were examined by using
AMES test. Elution of test samples were carried out in DMSO and physiological saline
and aliquots of serially diluted elutes were used for the assay. Only glutaraldehyde
containing agent showed a mutagenic effect on S. typhimurium TA102 strain [70]. In
another study, the mutagenic potentials of 12 commercially available dental cements
used in root canal filling were determined by AMES test. Only one test sample showed
mutagenic effect on both TA98 and TA100 strains of S. typhimurium [71].
2. 5. Biomaterial-Bacterial Interactions
Biofilms can be described as microecosystems in which different microbial
strains and species efficiently cooperate to protect themselves against environmental
factors and to facilitate more efficient nutrient uptake [72]. Formation of biofilms is
seen in some biomaterial applications and that causes biomaterial-centred infections in
humans. These infections are troublesome because biofilm organisms are protected
against the host immune system and antibiotics cannot eradicate easily. As a result, an
infection around or on biomaterial leads to degradation or loosening of the implant,
reoperation, osteomyelitis, amputation or death [73].
Adhesion of pathogenic bacteria to material surfaces is the initial stage in the
pathogenesis of prosthetic infections. In these infections, bacteria come from two
sources. The first one is direct contamination of the wound during surgery from
patients skin and air. The second type of contamination is hematogenous or lymphatic
seeding from infections present in the other parts of body [74-76].
Staphylococcus aureus, one of the causative agents of ostemyelitis, is a usual
pathogen associated with damaged tissue. S. epidermidis, a nonpathogenic skin
saprophyte, attach to the surface of vascular grafts and catheters and  becomes an
important pathogen in the presence of biomaterials. S. epidermidis is responsible for one
half or more orthopaedic infections. S. epidermidis preferentially adhere to polymer
surfaces and S. aureus to metal surfaces [77]. Additional microorganisms mostly seen in
biomaterial-centred infections are E. coli, Peptococcus, P. aeruginosa, Proteus
mirabilis, β-hemolytic streptococcus, Klebsiella group and Micrococcaceae [77,78].
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Bacterial adhesion to biomaterial surfaces takes place in a few stages. The initial
stage is the bacterial attachment. This is a physical contact between bacteria and implant
materials and usually is reversible. In the following step, bacteria adhere firmly to the
surface by a complete interaction, including a time-dependent phase of irreversible
chemical and cellular adherence [77]. In bacterial adhesion, physicochemical
interactions between bacteria and material surface take place. By the effects of physical
forces, such as Brownian motion, van der Waals attraction forces, gravitational forces,
the effect of surface electrostatic charge and hydrophobic interactions bacteria move to
a material surface. In the case of short-range interactions in which cell and surface come
into close contact (<3 nm), chemical bonds, such as hydrogen bonds, ionic and dipole
interactions or hydrophobic interactions occur [77]. Bacteria in aqueous suspensions are
always negatively charged. High surface charge is represented by a hydrophilic
character of bacteria, but a hydrophobic bacteria may still have a high surface charge
[79]. Surface charge of bacteria depends on bacterial species and is affected by growth
medium, bacteria age and bacterial surface structure [80]. Bacteria with hydrophobic
properties prefer hydrophobic surfaces and hydrophilic bacteria tend to adhere
hydrophilic material surfaces. In fact, hydrophobic bacteria adhere to a greater extent
than hydrophilic bacteria [81-83].
After the physicochemical interactions, molecular interactions between bacteria
and substratum surfaces are seen. In this case, bacterial surface polymeric structures,
which include capsules, fimbriae or pili and slime, play important roles. Capsules can
be seen in stained and unstained preparations as a clear zone surrounding both gram-
positive and gram-negative bacteria. Capsules are composed of polysaccharides and
proteins that act as bacterial adhesins. Fibrillar structures were observed at the surface
of various streptococci and these structures help to bacteria for better adhesion onto HA
substrata [84]. Slime is an extracellular substance of bacteria that may be partially free
from the bacteria after dispersion in a liquid medium [85]. Slime is made up with
polysaccharides and it is important for intercellular interaction during surface
colonization [86,87]. Bacteria washed to remove slime showed a similar amount of
adhesion to poly(tetrafluorethylene-co-hexafluorprophylene) compared to non-washed
bacteria [88]. Therefore, bacterial strains producing slime are more adherent and more
pathogenic than non-producing strains [89-92].
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The characteristics of material surfaces influence the bacterial adhesion process.
Chemical composition, surface charge, hydrophobicity, surface roughness and physical
configuration of material surfaces are the main factors in the adhesion. In addition,
binding of serum or tissue proteins to material surfaces may change adherent behavior
of bacteria. For example, fibronectin promotes adhesion of S. aureus to substratum [93-
97] and fibrinogen increases especially adherence of staphylococci to biomaterials. The
promoting effect of laminin on S. aureus is in lesser extent than fibronectin and
fibrinogen [98]. However, surface-adsorbed albumin inhibits adhesion of bacteria to
polymer, ceramic and metal surfaces. Furthermore, pre-incubation of Teflon catheters in
human serum led to 80-90% decrease in the adhesion of S. epidermidis [77].
Inhibition of biofilm formation is achieved by using broad-spectrum antibiotics,
such as penicillins or cephalosporins, before and after surgery [77]. In addition, slow-
release of antibiotics from surface or by changing physiochemical properties of surfaces
are the other strategies to prevent bacterial adherence. Combinations of alkyl
phosphates, a disodium phosphate of 1-octadecanol and non-ionic surfactant coating of
HA led to inhibition of S. mutans adhesion by 98% [99]. Another potential coating
material is silver. Polyurethane discs with silver coating resulted in 10-100-fold
reduction in the number of adherent E. coli compared with untreated control samples
[100]. Protein coating was applied successfully for preventing bacterial adhesion. Many
biologically active proteins including albumin, fibrinogen, fibronectin, laminin and
denatured collagen were studied. Among them, albumin showed inhibitory effects on
the adhesion of S. aureus and S. epiderimidis. In addition to inhibitory effects of
albumin, it prevents platelet aggregation and activation as well as improving
biocompatibility of biomaterials [77].
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Chapter 3
MATERIALS AND METHODS
3. 1. Materials
For mammalian cell culture experiments, Roswell Park Memorial Institute
(RPMI)-1640 medium, Fetal Bovine Serum (FBS), gentamycin sulfate, concanavalin A
(Con A), lipopolysaccharide (LPS), trypan blue, Bovine Serum Albumin (BSA), MTT
and DMSO were purchased from Sigma Chemical Company. Heparin-sodium
(Lequimine) was from Roche. Biocoll cell separation solution (Ficoll with density 1.071
g/ml) was obtained from Biochrom Chemical Company. Potassium monohydrogen
phosphate, potassium dihydrogen phosphate, sodium chloride were obtained from
Mérck Chemical Company. Tissue culture plates were from Corning Costar,
polypropylene tubes and disposable pipettes were obtained from Greiner. Cell
proliferation assay kit was purchased from Amersham Life Sciences. Quantikine
Human IL-1α and IL-6 ELISA kits were from R&D Systems.
In bacterial culture studies, Luria broth and Luria agar were purchased from
Sigma Chemical Company. Mueller-Hinton agar, Mueller-Hinton broth, nutrient broth
no:2, meropenem and vancomycin antibiotic discs were from Oxoid. The culture media
for Viridans spp. BacT was supplied by Organon Teknika. Bacterial stains; methylene
blue from Mérck, acid fuchsin and bacteriological agar were obtained from Difco.
Salmonella typhimurium strains were obtained from Prof. Bruce Ames (Biochemistry
Department, University of California, Berkeley). E.coli, S. aureus, Viridans (S. mitis
and S. mutans), S. pyogenes, P. aeruginosa, Proteus spp. and Enterobacter spp. strains
were kindly provided by Prof. Dr. Altõnay Bilgiç (Dept. of Microbiology and Clinical
Microbiology, Faculty of Medicine, Ege University, İzmir).
Calcium phosphate (tri basic) was obtained from Aldrich Chemical Company.
Alumina powder was from Sumitoma AKP-50 and zirconia powder was from Tosoh
TZ-3Y. Stainless steel (316L), titanium alloy (Ti-6Al-4V) and cirulene (ultra high
molecular weight polyethylene) discs were kindly supplied by Dr. Cevdet Alptekin
(Hipokrat Tõbbi Malzemeler İmalat ve Pazarlama A.Ş., İzmir).
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3. 2. Methods
3. 2. 1. Preparation of Biomaterials and Test Samples
Ceramic and composite pellets were prepared in İzmir Institute of Technology,
Faculty of Engineering Laboratories. In order to prepare HA pellets, 1.5 g of
polyvinylalcohol (PVA) was dissolved in 25 ml deionized water (dH2O) on a hot plate
by stirring and mixed with 50 g of calcium phosphate (tri basic) (HA). After drying the
mixture at 100 °C by mixing at 10-15 minutes intervals, the powder form was obtained
by grinding in a mortar.
Table 3.1. The weight and compaction pressure of ceramic pellets
Ceramic Material 15 mm diameter die 5 mm diameter die
Powder
(gram)
Pressure
(MPa)
Powder
(gram)
Pressure
(MPa)
Hydroxyapatite 0.70 180 0.070 240
Alumina 0.90 180 0.090 240
Zirconia 1.20 180 0.140 240
HA-Alumina 0.75 180 0.085 240
HA-Zirconia 0.80 180 0.090 240
The HA green pellets were sintered at mainly 800 °C and 1250 °C by using a high
temperature oven (Carbolite RHF 1600). In addition, for some tests HA pellets were
sintered at 900 °C, 1000 °C, 1100 °C and 1400 °C. Alumina and zirconia pellets were
prepared in a similar way and sintered at 1450 °C. HA-Alumina composites were
prepared by mixing 4 g HA and 1 g alumina powder. Similarly, HA-Zirconia
composites were prepared by mixing 4 g of HA and 1 g of zirconia powder. In the
preparation of samples, 1 g alumina powder was suspended in 2 ml dH2O and sonicated
for 8 minutes. Then, 4 g HA powder was added and ultrasonically treated for 8 more
minutes. 1.25 ml dissolved PVA in dH2O was added and dried at 100 °C by mixing at
10-15 minutes intervals. The powder form was obtained by grinding dried composite
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mixture. HA-Zirconia composite powders were also prepared similarly. Composite
pellets were sintered at 1250 °C.
Metallic biomaterials (stainless steel (316L) and titanium alloy (Ti-6Al-4V))
were supplied by Hipokrat A.Ş. with 10-14 mm in diameter and 2 mm in thickness. For
polishing process, the molds were prepared by using polymer resin material in
Simplimet 2 mounting press (Buehler). The samples were polished by using 1200 grit
SiC, 6 microns diamond suspension, 1 microns alumina and 0.5 microns alumina
suspensions on Metaserv 2000 grinder/polisher (Buehler). The surface roughness of
polished samples was examined by using an optical microscope (Olympus BX60M
reflected light version). In addition, polymeric sample (ultra high molecular weight
polyethylene) was obtained from Hipokrat A.Ş. with 10-14 mm in diameter and 2 mm
in thickness.
All ceramic samples were washed 4-5 times with dH2O for cleaning. Metallic
discs were cleaned with methanol and DLC coated AISI 52100 disc was cleaned by
sonication 2 times for 15 minutes in acetone. Metallic samples were washed with dH2O
several times and dried at 100 °C for 1-1.5 hours. After covering with aluminium foil,
they were sterilized by dry heat at 200 °C for 2 hours. However, cirulene samples were
wrapped with cheesecloth and autoclaved at 121 °C for 15 minutes.
3. 2. 1. 1. Protein Adsorption to Ceramic Pellets
Bovine Serum Albumin (BSA) adsorption studies were carried out by incubating
ceramic pellets (15 mm in diameter) in 10 ml protein solution with a concentration of 20
mg/ml BSA in sodium phosphate buffer (pH 7.3). The samples were incubated at 37 °C
with shaking at 110 rpm for 3 hours in a thermal shaker (Gerhardt Thermoshake). The
pellets were immediately used or stored at +4 °C until use.
3. 2. 2. Isolation of Peripheral Blood Mononuclear Cells (PBMC)
Peripheral blood is the primary source of lymphoid cells for the examination of
immune responses in humans. Density gradient centrifugation with Ficoll is a simple
and rapid method for the purification of PBMC on the basis of difference in the
densities of leukocytes and other blood elements [101]. While Ficoll sucrose polymer
aggregates the erythrocytes in the bottom, low density PBMC and platelets form a layer
on the top of gradient. Platelets are removed by washing with PBS. The prepared
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PBMC population contains 5% B-lymphocytes, 5-15% monocytes, 60-70% T-
lymphocytes, and 5-15% Natural Killer Cells [102].
PBMC were freshly isolated from healthy, non-smoking men and women donors
with ages between 24 and 30 as described by Hokland M. et al. [103]. Isolation
procedure is described in Figure A1. In summary, 10 ml blood was taken into
heparinized needle with 400 µl sterile heparin-sodium solution (50 I.U.). The blood was
transferred into 2 sterile tubes and equal volume of sterile 0.9% NaCl was added. 5 ml
of NaCl-blood mixture was taken by sterile, pasteur pipette and layered onto 3 ml Ficoll
solution (density 1.071 g/ml) very slowly to prevent disruption of the layer in a conical
bottom falcon tube. The tubes were centrifuged at 1600 rpm (Hettich 30RF Centrifuge),
at room temperature for 25 minutes. At the end of centrifugation, a buffy coat layer of
PBMC was obtained. The layer between plasma and Ficoll was carefully removed into
new tubes and 4-5 volumes of PBS (pH 7.4) containing 2% FBS were added. The cells
were centrifuged at 800 rpm for 10 minutes. After removing the supernatant, the pellet
was resuspended with 10 ml PBS containing 2% FBS and centrifuged at 500 rpm for 8
minutes. This washing was repeated once more to remove thrombocytes and platelets.
The pellet was resuspended in RPMI-1640 medium (pH 7.4) containing 15% FBS and
50 µg/ml gentamycin sulfate. Isolated cell number was determined by mixing 50 µl cell
suspension with 50 µl trypan blue solution (0.4 %) and the cells were counted
immediately in 25 squares of hemocytometer by using light microscope. The following
formula gives the number of cells per ml:
Number of cells/ml = Number of cells counted in 25 square × Dilution factor × 104
3. 2. 3. The Viability of PBMC
The effects of biomaterials on the viability of PBMC were determined by using
trypan blue exclusion method. For this purpose, HA pellets (sintered at 800 °C, 900 °C,
1000 °C, 1100 °C, 1250 °C), alumina pellets (1000 °C, 1450 °C), zirconia pellets (1450
°C), their extracts in PBS, stainless steel (316L), titanium alloy (Ti-6Al-4V), cirulene
(ultra high molecular weight polyethylene) pellets and BSA-coated samples were used.
PBMC at 2.5×105 cells/ml were incubated in the presence of sterile samples at 15 mm in
diameter in sterile 24-well polystyrene tissue culture treated plates. Some of the cells at
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1×105 cells/well were incubated with the extracts of biomaterials in 96-well flat bottom
tissue culture treated plates. Incubation was carried out for 24, 48 and 72 hours at 37 °C
with 5% CO2, humidified incubator. The procedure of the method is described in Figure
A2. At the end of incubation periods, the cells were collected into eppendorf tubes and
centrifuged at 100 rpm for 10 minutes for settlement of the cells. The supernatant was
removed until 100-200 µl remained in eppendorf tubes. The cells were resuspended
slowly with a micropipette and 50 µl of the cell suspension was mixed with 50 µl trypan
blue solution (0.4 %). Live and dead cells were counted immediately by using
hemocytometer under light microscope. Dead cells absorbed the blue dye due to the
damage in the cell membranes and they appeared in blue color. The viability of cells
was calculated by the following formula:
Percent Cell Viability = [Number of live cells / Number of total cells (live+dead)] × 100
3. 2. 4. IL-1α and IL-6 Secretion from PBMC
The secretions of IL-1α and IL-6 in the presence of biomaterials were
determined by using Quantikine ELISA kits (R&D Systems). Briefly, PBMC (2.5×105
cells/well) were incubated with sterile samples at 15 mm in diameter in 24-well tissue
culture plates at 37 °C with 5% CO2, humidified incubator for 17 hours with and
without LPS (10 µg/ml). The cell suspensions were collected into eppendorf tubes and
centrifuged at 15,000 rpm for 30 seconds by using a microcentrifuge (Techne Genofuge
16M). The supernatants were collected into new eppendorf tubes and stored at 20 °C to
conduct ELISA experiments.
Human IL-1α secretion in the cell culture supernatants was determined by the
quantitative sandwich enzyme immunoassay technique as described by the
manufacturer. Briefly, 200 µl standards and sample supernatants were pipetted into a
microtiter plate, which was pre-coated with a monoclonal antibody specific for IL-1α.
After 2 hours incubation at room temperature, the microtiter plate was washed 3 times
to get rid of unbound substances. Horseradish peroxidase conjugated polyclonal
antibody specific for IL-1α was added to the wells. Following 1-hour incubation period
at room temperature, unbound antibody-enzyme reagent was removed and a substrate
solution was added to the wells. After 20 minutes incubation, the color development
30
was stopped with stop solution. Absorbance of the color development in proportion to
the amount of IL-1α bound in initial step was measured at 450 nm with an ELISA plate
reader (ELX 800 Universal Plate Reader, Bio-Tek Instruments).
The same strategy was applied to determine IL-6 secretion in the supernatants
from PBMC culture incubated with indicated biomaterials.
3. 2. 5. The Proliferation of PBMC
The proliferation of PBMC was determined as described in the Biotrak cellular
communication assays, cell proliferation ELISA system version 2 kit (Amersham Life
Sciences). The test is based on the incorporation of the pyrimidine analogue 5-bromo-
2′-deoxyuridine (BrdU) instead of thymidine into the DNA of proliferating cells. PBMC
(8×104 cells/well) were incubated in 96-well flat bottom tissue culture treated plate with
the biomaterials (5 mm in diameter) at 37 °C with 5% CO2, humidified incubator for 2
days. Con A (5 µg/ml) was added into the cell culture as a positive control for cell
proliferation. After that, BrdU was added to the cells and incubation was carried out for
additional 24 hours to label DNA. The cells were centrifuged at 1200 rpm for 15
minutes at room temperature in a plate rotor of Hettich 30 RF Centrifuge. After
removing the culture medium, the cells were dried and fixed with hair dryer for 15
minutes. DNA was denatured with fixative solution for 60 minutes incubation. Fixative
was removed by tapping and 200 µl/well blocking reagent was added (blocking stock
solution was diluted 1:10 with dH2O) and incubated for 30 minutes at room
temperature. Blocking reagent was removed and 100µl/well peroxidase-labelled anti-
BrdU working solution was added and incubated for 2 hours at room temperature.
Peroxidase-labelled anti-BrdU working solution was prepared just before use and it is
not stored. Peroxidase-labelled anti-BrdU stock solution was diluted 2:100 with
antibody dilution solution. In this period, peroxidase-labelled anti-BrdU binds to the
BrdU incorporated in newly synthesized, cellular DNA. Antibody solution was removed
by tapping and the wells were washed 3 times with 200-300 µl wash buffer.
Immediately, 100 µl room temperature equilibrated TMB substrate solution was added
and incubated for 5-30 minutes at room temperature by covering aluminium foil and by
shaking on an orbital shaker until color development. When color development was
achieved, reaction was stopped by pipetting 25 µl of 1M sulphuric acid into each well
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and mixed slowly. Optical density at 450 nm was determined within 5 minutes using an
automated ELISA plate reader (ELX 800 Universal Plate Reader, Bio-Tek Instruments).
3. 2. 6. The Activation of PBMC (MTT Assay)
The activation of PBMC was determined by MTT assay. This assay also
represents cytotoxic effects of biomaterials. The test is based on the conversion of
yellow water-soluble substrate 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide to purple water insoluble formazan crystals by mitochondrial enzymes of
metabolically active cells.
Sterile HA 800 °C, HA 900 °C, HA 1100 °C, HA 1250 °C, HA-Alumina 1250
°C, HA-Zirconia 1250 °C pellets (5 mm in diameter) and the extracts of HA 800 °C,
HA 900 °C, HA 1000 °C, HA 1250 °C, alumina 1450 °C and zirconia 1450 °C in PBS
(pH 7.4) were tested for the activation of PBMC. The test procedure is described in
Figure A3. The samples were incubated with 1×105 cells/well in 96-well tissue culture
treated plates for 24 hours, 48 hours and 72 hours at 37 °C with 5% CO2, humidified
incubator. MTT stock solution (5 mg/ml) was added into each well at 1:10 ratio for last
3 hours of incubation period. At the end of each incubation period, the cells incubated
with ceramic pellets were highlighted and transferred into blank wells. The plate was
centrifuged at 1800 rpm for 10 minutes at room temperature in a plate rotor of Hettich
30 RF Centrifuge to avoid accidental removal of formazan crystals. Supernatants were
removed by tapping slowly on a paper towel. DMSO (150 µl) was added into each well
and mixed on an orbital shaker at 150 rpm for 5 minutes. The absorbance values were
determined at 540 nm (690 nm reference wavelength) by using an automated plate
reader (Organon Teknika Reader 230 S, Version 1.22).
3. 2. 7. AMES Mutagenicity Test
Mutagenic potential of biomaterials was determined by using AMES test [68].
Reverse mutations of tester Salmonella strains are detected for their histidine
dependence or independence.
The extracts for mutagenicity test were prepared by incubating sterile ceramic
samples with 5 ml PBS (pH 7.4) and sterile metallic samples with 7 ml PBS (pH 7.4) in
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sterile 6-well polystyrene tissue culture treated plates at 37 °C with 5% CO2, humidified
incubator for 120 hours without shaking. The extracts were stored at 20 °C.
The procedure of AMES mutagenicity test is described in Figure A4. Briefly,
Salmonella typhimurium strain TA 100 was grown in nutrient broth no:2 in test tubes or
in 50 ml flasks at 37 °C with shaking overnight in a thermal shaker (Gerhardt
Thermoshake). To prevent effects of light on the viability of bacteria, tubes or flasks
were covered with a aluminium foil during incubation and experiment. Next day, 0.5 ml
PBS (pH: 7.4), 0.1 ml of bacterial culture and 0.1 ml biomaterial extracts were mixed
slowly by vortex and incubated for 1 hour at 37 °C with shaking. After preincubation of
the bacteria with the extracts, 2 ml top agar containing 0.5 mM Histidine-Biotin was
added into tubes, mixed slowly by vortexing at low speed for 3 seconds and poured onto
glucose agar plates immediately. Uniform distribution of top agar on glucose plates was
achieved. Duplicate plates were incubated at 37 °C for 48 hours and the revertant
colonies with background lawn were counted. The revertant colonies in the negative
control (no extract), in the positive control (5 µl sodium azide (17.2 mg/ml)) plates and
in the plates with top agar containing only biotin were compared for the mutagenic
potentials of biomaterials.
3. 2. 8. Bacterial Adhesion to Biomaterial Surfaces
For the determination of bacterial adhesion to biomaterial surfaces, S. aureus, E.
coli, Viridans (Streptococcus mutans and Streptococcus mitis) and KNS (Koagulase
negative Staphylococcus) bacterial strains were used. Briefly, the test procedure is
explained in Figure A5. Dry heat sterilized metallic and ceramic pellets were placed in
polystyrene, 90 mm in diameter, sterile, 4 partitioned plates. 6 ml of LB broth (pH: 7.4)
for S. aureus, E.coli and KNS strains, 6 ml of BacT Medium for Viridans strains were
added into each partition of plates. Dilutions of bacterial suspensions in sterile dH2O
were prepared according to McFarland 0.5 (108 CFU/ml) and 0.1 ml was added into
each part. The plates with S. aureus and E. coli were incubated for 6 hours and the
plates with Viridans and KNS for overnight at 37 °C with shaking at 40 rpm in a
thermal shaker (Gerhardt Thermoshake). The pellets were washed with sterile dH2O 4-5
times to remove unbound bacteria from the surface and transferred into new plates.
After air drying, bacteria on the pellets were fixed on hot plate for 30 seconds or at 60
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°C for 1 hour and stained with methylene blue or acid fuchsin (Bacto TB carbolfuchsin
KF) for 30 seconds. The pellets were washed with dH2O to remove excess stains and
they were air dried before examination under an optical microscope (Olympus BX60M
reflected light version). Photographs were taken by using Olympus semiautomatic
exposure photomicrography system.
3. 2. 9. Anti-Bacterial Effects of Biomaterials
The agar diffusion method was used to determine anti-bacterial effects of
biomaterials. Gram-negative bacterial strains (E. coli, Pseudomonas aeruginosa,
Klebsiella pneumonia and Proteus spp.) and gram-positive strains (S. aureus and
Streptococcus pyogenes) were used for this assay. One colony was picked up from the
bacteria grown on blood agar plates for overnight and it was dissolved in 1 ml sterile
dH2O with a concentration of McFarland 1.0 (109 CFU/ml). Each bacterial suspension
was spread onto separate Mueller-Hinton agar plates. Powder forms of ceramic
biomaterials (0.05 g), sintered ceramic pellets, metallic and polymeric biomaterials were
applied on the plates aseptically. Meropenem (10 µg) and vancomycin (30 µg) were
used as the positive controls. The plates were incubated at 37 °C with 5% CO2,
humidified incubator. The zone diameters around test materials and the positive controls
were measured everyday.
3. 2. 10. Dissolution Properties of Biomaterials
Dissolution properties of ceramic materials (HA, alumina and zirconia at
different sintering temperatures) in the culture medium (RPMI-1640 with 15% FBS and
50 µg/ml gentamycin sulfate) with and without PBMC and in deionized water were
examined. Sterile HA 800 °C, HA 1250 °C, alumina 1450 °C and zirconia 1450 °C
pellets (15 mm in diameter) were used in this assay. The pellets were incubated with 1
ml of 2.5×105 cells/well in sterile 24-well tissue culture treated plates at 37 °C with 5%
CO2, humidified incubator for 4 hours and 72 hours. In 4 hours period, every hour, in 72
hours period, in 4 hours intervals and in 10 days period, everyday the samples were
taken. At the beginning (time 0) and at the end of each time point, 1 ml cell suspension
and 1 ml culture medium were collected into 50 ml sterile falcon tubes and the volume
was completed to 25 ml with sterile dH2O. For 10 days period, 2 ml dH2O in the wells
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were collected and brought to the total volume of 24 ml with dH2O. The conductivity
and pH of solutions were measured by using WTW Inolab Cond Level 2P Conductivity
Meter and Hanna Instruments HI 9321 Microprocessor pH Meter.
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Chapter 4
RESULTS AND DISCUSSION
4. 1. Effects of Biomaterials on The Viability of PBMC
Ceramic materials with different sintering temperatures, their extracts in PBS,
BSA adsorbed ceramic materials, polished and unpolished metallic samples and
polymeric samples were examined to see if they have any effects on the viability of
PBMC culture.
Hydroxyapatite pellets 15 mm in diameter were sintered at 800 °C and 1250 °C,
alumina pellets at 1450 °C and zirconia pellets at 1450 °C. Ceramic materials were
incubated with freshly isolated human PBMC (2.5×105 cells/ml) for 24, 48 and 72
hours. The cells were collected and stained with trypan blue. Percent cell viabilities
were calculated as described in Materials and Methods Section. In the evaluation of the
effects of ceramic materials on the viability of cells, data were compared with the
control culture which contains no biomaterial. After 24 hours incubation, the cell
viability was not affected by HA 1250 °C, alumina 1450 °C and zirconia 1450 °C
samples. However, HA 800 °C sample caused 1.3-fold decrease in the cell viability
compared to the control culture (Figure 4.1). In addition, the viability of cells treated
with HA 800 °C sample continued to decrease 3.3-fold and 3.9-fold when compared to
the control cultures after 48 hours and 72 hours treatments, respectively. In contrast to
HA 800 °C sample, other biomaterials tested did not cause a significant change in the
cell viabilities after 48 and 72 hours treatments.
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Figure 4.1. Effects of ceramic biomaterials on the viability of PBMC. PBMC at
2.5×105 cells/well were incubated with ceramic samples for 24, 48 and 72 hours.
The cells were collected by centrifugation at 100 rpm for 10 minutes and stained
with trypan blue. Live and dead cells were counted by hemocytometer and percent
cell viability was determined as explained in Materials and Methods Section. Data
are the average of duplicate samples from separate experiments.
In the first set of experiments, HA 800 °C pellets led to a change in the red color
of culture medium to purple. Purple color in medium represents a basic solution.
Because of the pH change of the medium, number of live cells might decrease. The
reason of the pH change could be due to the dissolution of HA 800 °C pellets in the
culture medium. Unlike HA 1250 °C and other ceramic samples, HA 800 °C pellets
have porous structure, so that they have a relatively high surface area. In order to
determine the negative effect of low sintering temperature, HA pellets with different
sintering temperatures between 800 °C and 1250 °C were prepared. Alumina pellets at
low sintering temperatures (1000 °C) were also prepared for the investigation of the
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effects of low sintering temperature (porous structure of pellets) or chemical
composition on the cell viability. PBMC 2×105 cells/well were incubated with indicated
ceramic samples sintered at different temperatures for 24, 48 and 72 hours (Figure 4.2).
After 24 hours, the viability of cells treated with HA 800 °C, HA 900 °C and HA 1000
°C pellets was 1.6-, 1.7- and 1.4-fold less than that of cells without any ceramic
samples. HA pellets sintered at 1100 °C and 1250 °C did not affect the cell viability at
all time points examined. After 48 hours incubation, the viability of cells decreased to
30% and 35% in the cells treated with HA 800 °C and HA 900 °C; however, there was a
slight decrease in the viability of cells treated with HA 1000 °C pellet. After 72 hours,
the viability reduced to 30% and stayed around at the same level for all HA pellets
sintered at low temperatures: 800 °C, 900 °C and 1000 °C (Table B2).
In addition, the effect of alumina pellets sintered at different temperatures on the
viability of PBMC was examined. After 24 hours incubation, alumina sintered at 1000
°C caused 1.11-fold decrease in the cell viability compared to the control culture. The
cell viability decreased to 50% at 48 hours; the last time point examined (Figure 4.2;
Table B2). The effect of alumina pellet sintered at 1450 °C on the viability of PBMC
was tested only at 48 hours incubation period and the percent cell viability (85%) was
close to that obtained from the control culture (95% out of maximum level). On the
basis of these data, both porous structure and chemical composition of ceramics seem to
affect the viability of PBMC. The chemical composition of ceramics changes with
sintering temperature. At high temperatures, they are very dense. However, at low
temperatures they have highly porous structure and low density.
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Figure 4.2. Effects of sintering temperatures on the viability of PBMC. 2×105
cells/well were incubated with ceramic pellets (15 mm in diameter) with different
sintering temperatures between 800 °C and 1450 °C for 24, 48 and 72 hours.
Percent cell viabilities were calculated as legend to Figure 4.1. Data are the average
of duplicate samples from separate experiments.
The extracts of ceramic samples were obtained by incubating sterile pellets in 5
ml PBS (pH 7.4) in sterile 6-well polystyrene tissue culture treated plates at 37 °C with
5% CO2, humidified incubator for 120 hours without shaking. The extracts were stored
at -20 °C until used. PBMC (1×105 cells/well in 96-well tissue culture treated flat
bottom plates) were incubated with the extracts of HA 800 °C, HA 1250 °C, alumina
1450 °C and zirconia 1450 °C pellets (5 µl, 10 µl, 20 µl, 40 µl) for 24 hours, 48 hours
and 72 hours. Percent cell viabilities were calculated as shown in Table B3. After 24
hours incubation, the percent cell viabilities did not show significant differences in
comparison to the control culture (Figure 4.3-A). Moreover, the increase of extract
concentration in the cell culture did not affect the cell viability. After 48 hours
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incubation, no effect on the cell viability was observed after treatment of the cells with 5
µl of all extracts (Figure 4.3-B). However, increased concentration of zirconia 1450 °C
extracts (10 µl, 20 µl and 40 µl) resulted in 10%, 4% and 7% decrease in the cell
viability, respectively. Similarly, 8% and 6% decline in the cell viabilities was observed
in the cells treated with 20 µl and 40 µl HA 800 °C extracts. Alumina 1450 °C extract
(20 µl) caused 10% decrease in the cell viability, but it had no effect at other
concentrations. At the end of 72 hours, slight fluctuation was investigated in the cell
viabilities after treatment with all the extracts at different concentrations. However, only
HA 800 °C extracts at 10 µl and 40 µl concentration gave rise to a 14% and 25%
decrease, respectively in the cell viability (Figure 4.3-C; Table B3). As a result of these
data, a negative correlation between increasing extract concentration and the cell
viability was observed for all samples.
A.
80
82
84
86
88
90
92
94
96
98
100
5 10 20 40 Control
(Without
Biomaterial)
Amount of Extracts (microlitre) 
Pe
rc
en
t C
el
l V
ia
bi
lit
y
HA 800 °C HA 1250 °C Alumina 1450 °C Zirconia 1450 °C
40
60
64
68
72
76
80
84
88
92
96
100
5 10 20 40 Contol
(Without
Biomaterial)
Amount of Extracts (microlitre) 
Pe
rc
en
t C
el
l V
ia
bi
lit
y
HA 800 °C HA 1250 °C Alumina 1450 °C Zirconia 1450 °C
Figure 4.3. Effects of ceramic extracts on the viability of PBMC.
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Extracts of ceramic samples were obtained by incubating pellets (15 mm in
diameter) in PBS (pH 7.4) at 37 °C for 120 hours without shaking. 200 µl PBMC
(1×105 cells/well in 96-well plate) were incubated in the presence of 5 µl, 10 µl, 20
µl, 40 µl extracts. Percent cell viabilities were determined at the end of 24 hours
(A), 48 hours (B) and 72 hours incubation (C). Data are the average of duplicate
samples from separate experiments.
In order to determine the effect of protein (BSA) adsorption onto ceramic
samples on the cell viability, PBMC (2.5×105 cells/well) were incubated with BSA-
adsorbed ceramic samples for 24 hours, 48 hours and 72 hours. The data obtained from
protein adsorbed samples (Table B4) were compared with previously obtained data
from uncoated ceramic samples (Table B1). Except for protein adsorbed HA 800 °C
pellets, all samples showed similar results with the controls at all time points. In the
case of protein coated HA 800 °C pellets, after 24 hours 13%, after 48 hours 102% and
after 72 hours 62% increase in the viability of PBMC were obtained with respect to
uncoated HA 800 °C pellets (Figure 4.4).
In the literature, Deligianni et al. reported that cell adhesion, proliferation and
detachment strength were surface roughness sensitive and increased as the roughness of
HA increased. In addition, the adhesion of cells such as human bone marrow cells on
HA surfaces and the cell detachment strength may be explained by the selective
adsorption of proteins present in serum [104]. These adsorbed proteins play important
roles in the modulation of cellular interactions. For example, adsorption of serum
fibronectin to the surface of calcium phosphate may be responsible for enhanced
osteoblast adhesion [105]. The high surface area because of porous structure of HA 800
°C led to the adsorption of more protein. Therefore, the protein adsorption, which
probably prevents the dissolution of HA pellets or leads to a decrease in the negative
effect of HA 800 °C on the cell viability by attachment of the cells.
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Figure 4.4. Effects of protein adsorption onto ceramic pellets on the viability of
PBMC. BSA adsorbed ceramic pellets (15 mm in diameter) were incubated in 10
ml BSA (20 mg/ml) in sodium phosphate buffer (pH 7.3) at 37 °C with shaking at
110 rpm for 3 hours. Coated ceramic pellets were incubated with PBMC (2.5×105
cells/well) for 24, 48 and 72 hours. The percent cell viabilities were obtained by
trypan blue exclusion method. Data for uncoated samples were adapted from
Table B1. Data for protein adsorbed ceramic samples represent results of one
experiment.
The effects of metallic biomaterials (polished and unpolished stainless steel
(316L), titanium alloy (Ti-6Al-4V)) and polymeric biomaterial (cirulene, (ultra high
molecular weight polyethylene)) 10 mm in diameter and 2 mm in thickness on the
viability of PBMC were tested. Freshly isolated PBMC (2×105 cells/well in 24-well
plates) were incubated with the samples at 37 °C with 5% CO2 for 24, 48 and 72 hours.
In polished stainless steel samples after 24 and 48 hours, no dead cells were observed
and percent cell viabilities were calculated as 100%. After 24 hours and 48 hours, there
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were no more than 3% decreases in the cell viabilities in the presence of metallic and
polymeric samples with respect to the control cultures (Figure 4.5). Whereas, after 72
hours, a decrease in the viability of PBMC was obtained. Stainless steel, polished
stainless steel, titanium alloy, polished titanium alloy and cirulene resulted in 22%, 5%,
10%, 4% and 16% respectively, decrease in the cell viability (Table B5). After 72 hours
incubation with the cells, metallic samples and polymeric sample started to decrease the
cell viabilities. Before 72 hours, they showed similar results with the control culture. In
fact, release of some ions might change the ionic environment of the culture medium.
These results suggested that, surface properties of biomaterials are important for the
viability of cells. Especially in polished samples, almost 100% cell viabilities were
obtained. In optical microscope observation, very rough surface including lines and
scratches was observed in unpolished metallic samples, but not in polished samples.
Polished surfaces are more suitable for suspension cells, such as PBMC. However,
anchorage dependent cells, such as bone marrow cells and osteoblasts, prefer rough
surfaces for adhesion and proliferation.
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Figure 4.5. Effects of metallic and polymeric samples on the viability of PBMC.
44
Metallic samples (stainless steel and titanium alloy and their polished forms) and
polymeric sample (cirulene) 10 mm in diameter were incubated with PBMC (2×105
cells/well) for 24, 48 and 72 hours. Percent cell viabilities were determined as
legend to Figure 4.1. Data are the average of duplicate samples from separate
experiments.
In vitro cell culture systems simulate the biological environment of the body.
The samples were incubated for maximum 72 hours period with the cells. One
disadvantage in these experiments was the use of primary cells for the viability
measurements. Especially after 72-96 hours, these primary mononuclear cells start to
die due to waste products and depletion of food supply. These cells are also non-
adherent cells. For this reason, to change the culture medium is not possible. On the
other hand, PBMC play important roles in immune system, inflammation and
biomaterial-host interactions. All implant materials contact with blood consequently
mononuclear cells. To determine effects of biomaterials on the viability of PBMC is
crucial. The effects of these samples in long period of time should be tested to complete
their biocompatibility evaluation.
In the viability tests, porous HA pellets showed low response in in vitro culture
systems. However, the number of periosteal fibroblasts, osteoblasts and chondrocytes
increased 29-, 23- and 17-fold, respectively on to porous calcium phosphate ceramic
(sintered at 1100 °C for 8 hours) during 10 weeks period [106]. In fact, porous HA
showed appropriate results and biocompatibility for the adherent cells. In addition,
porous HA ceramics are widely used in medicine in the form of blocks or granules.
Some of the medical applications are filling bone defects, drug delivery systems,
alveolar ridge augmentation and orthognatic reconstruction [107].
4. 2. Effects of Biomaterials on The Secretion of Cytokines
IL-1α and IL-6 were quantitatively determined by using Quantikine ELISA
kits. Firstly, the calibration curves of IL-1α and IL-6 standards were plotted from
standard IL-1α and IL-6 solutions (Figure B1 and Figure B2). Test was repeated with
cells from different donors and in the presence and absence of mitogenic agent
lipopolysaccharide from E.coli 055:B5 (LPS) (Table B6). After 17 hours incubation of
45
ceramic pellets (15 mm in diameter) with PBMC (2.5×105 cells/well), the secretion of
IL-1α was detected. In the absence of LPS, there was no significant difference in IL-1α
secretion between all the samples and the control culture. In the presence of LPS, the
level of IL-1α secretion was highest in the control culture (Figure 4.6). There was a
slight decrease in IL-1α secretion of the cells treated with HA 1250 °C, alumina 1450
°C and zirconia 1450 °C samples. Unlike other samples, HA 800 °C, HA-Alumina 1250
°C and HA-Zirconia 1250 °C samples decreased the IL-1α secretion 5-fold, 3-fold and
2-fold, respectively when compared to the control culture.
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Figure 4.6. IL-1α secretion from PBMC in the presence of ceramics. PBMC
(2.5×105 cells/well in 24-well plates) were treated with ceramic samples and
ceramic-ceramic composite (HA-Alumina, HA-Zirconia) samples (15 mm in
diameter) for 17 hours with and without LPS (10 µg/ml). Supernatants were
collected after centrifugation. The level of IL-1α secretion from PBMC in the
presence of test samples were determined as described in Materials and Methods
Section. OD values directly represents IL-1α secretions. Data are the average of
duplicate samples from the same experiment.
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The effects of protein adsorbed ceramic, metallic and polymeric materials on
the secretion of IL-1α from PBMC were examined with and without LPS stimulation
and the cells from different donors (Table B7). Because BSA adsorption onto ceramic
samples especially HA 800 °C pellets increased the viability of PBMC when compared
to uncoated HA 800 °C pellets, the influence of BSA adsorption on HA 800 °C pellets
on the IL-1α secretion from PBMC was investigated. In the absence of LPS, BSA
coated HA 800 °C pellets led to 3-fold higher secretion of IL-1α than the control
culture. IL-1α secretion in BSA-coated HA 1250 °C, alumina 1450 °C and zirconia
1450 °C pellets was 1.7-, 1.6- and 1.8-fold higher than in the control, respectively.
However, in the presence of LPS, BSA-coated HA 800 °C pellets led to 30% decrease
in the secretion of IL-1α. BSA-coated HA 1250 °C, alumina 1450 °C and zirconia 1450
°C pellets caused 1.1-, 1.1- and 1.2-fold increase, respectively, in the secretion of IL-1α
(Figure 4.7). The results from BSA-coated and uncoated ceramic samples indicated that
in the absence of LPS, IL-1α secretion was higher in the cells treated with HA 800 °C
than the control. However, in the presence of LPS, IL-1α secretion in HA 800 °C
treated cells was less than the control. It is probable that the dissolution of HA particles
or ions affected the stimulatory effects of LPS on PMBC.
Metallic and polymeric samples were incubated with the cells as described
above. In the absence of LPS, there was no significant change in IL-1α secretion
compared to the control culture. Whereas, in the presence of LPS, these materials
resulted in 30%, 10% and 23% decrease respectively, in IL-1α levels (Table B7 and
Figure 4.7). As in the case of ceramic samples, ions or other factors might affect the
secretion of IL-1α from PBMC in the presence of metallic samples and LPS.
The amount of IL-1α secretions (pg/ml) was calculated from the formula of
calibration curve (Figure B1). Uncoated HA 800 °C pellets showed the lowest secretion
and BSA-coated ceramic pellets (HA 1250 °C, alumina 1450 °C and zirconia 1450 °C
pellets) showed the highest IL-1α secretions from PBMC (Table B8). Low secretion in
HA 800 °C pellets might result from death of cells. Because, low cell viabilities in HA
800 °C pellets were observed (Figure 4.1,Table B1). IL-1 plays important roles in
immune functions especially on monocyte/macrophages and lymphocytes. IL-1 induce
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its own synthesis as well as secretion of TNF and IL-6 secretions from
monocyte/macrophages. Normal production of IL-1 is obviously critical to mediation of
normal host responses to injury and infection. However, inappropriate or prolonged
secretions of IL-1 play roles in the formation of pathological conditions including
sepsis, rheumatoid arthritis, inflammatory bowel disease, acute and chronic
myelogenous leukemia, insulin-dependent diabetes mellitus, and atherosclerosis.
Therefore, low levels of IL-1 secretion in the presence of biomaterials in the body is the
desired condition. Biomaterials tested in the present study did not cause high
production of IL-1α secretions compared to the control cultures indicating that these
biomaterials are biologically compatible in this regard.
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Figure 4.7. IL-1α secretion from PBMC in the presence of protein coated ceramic,
metallic and polymeric samples. Ceramic samples were coated with BSA (20
mg/ml in sodium phosphate buffer (pH 7.3)). PBMC (2×105 cells/well in 24-well
plate) were incubated for 17 hours with 15 mm in diameter BSA-coated ceramic
pellets and 14 mm in diameter metallic and polymeric samples. LPS (10µg/ml) was
added to one set of samples. The level of IL-1α secretion from cells was determined
by using Quantikine human IL-1α ELISA kit. Data are the average of duplicate
samples from the same experiment.
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 In addition, IL-6 secretions from PBMC treated with biomaterials in the 
presence and absence of LPS were determined. IL-6 production of cells after treatment 
with ceramic pellets or ceramic-ceramic composites is shown in Figure 4.8 and Table 
B9. The level of IL-6 was the lowest in HA 800 °C treated cells (2.8-fold less than the 
control culture). In comparison with other biomaterials and the control culture, zirconia 
1450 °C pellet gave rise to the highest IL-6 production, which is 1.14-fold higher than 
that of the control culture. In stimulated cells with LPS, the absorbance values for IL-6 
production were higher than the limit of automated plate reader at 450 nm. Therefore, 
any data could not be taken from these samples.     
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Figure 4.8. Effects of ceramic biomaterials on the secretion of IL-6 from PBMC. 
PBMC (2.5×105 cells/well) (in the absence of LPS) were incubated with the ceramic 
pellets for 17 hours. The cells were precipitated by centrifugation at 15,000 rpm 
for 30 seconds. The supernatants were collected and tested for IL-6 secretion. IL-6 
levels were determined by using Quantikine human IL-6 ELISA kit. Optical 
densities at 450 nm directly represent IL-6 secretions. Data are the average of two 
separate experiments. 
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Moreover, the effects of BSA adsorption on ceramic samples on IL-6 production 
were tested. In the absence of LPS, both BSA-coated HA 800 °C and alumina 1450 °C 
pellets led to IL-6 production 7.5-fold higher than the control culture (Figure 4.9 and 
Table B10). In BSA-coated HA 1250°C and zirconia 1450 °C pellets, automated plate 
reader could not read absorbance values at 450 nm because they were out of range. In 
the presence of LPS, all samples were diluted with a factor of 4 in order to be able to 
obtain data. When IL-6 secretion was examined for the cells treated with BSA-coated 
ceramic samples in the presence of LPS, no significant differences were detected 
between the control culture and BSA-coated ceramic treated cultures. However, only in 
BSA-coated HA 800 °C pellet, IL-6 production was 26% less than the control culture in 
the presence of LPS. This result could be due to a decrease in the cell viability or the 
positive effect of protein coating.  
 Metallic samples (stainless steel, titanium alloy and DLC coated AISI 52100) 
and polymeric material (cirulene) were tested for the effects on IL-6 secretion from 
PBMC. In stainless steel and cirulene samples, 21% and 8% less IL-6 production than 
the control culture; in titanium alloy and DLC coated sample 16% and 144% higher IL-
6 production than the control were obtained. In stimulated cells with LPS, samples were 
diluted with the factor of 4. In stainless steel, titanium alloy and cirulene samples 12%, 
9% and 9% less IL-6 levels were detected in duplicate samples, respectively (Figure 4.9 
and Table B10).  
 The amount of IL-6 (pg/ml) in the presence of biomaterials and LPS was 
calculated from the formula of calibration curve (Figure B2). The results are presented 
in Table B11. 
As a result, BSA-coated HA 800 °C pellets increased IL-6 secretion compared to 
uncoated pellets. However, in HA 800 °C pellets released ions or particles affected the 
stimulatory role of LPS on PBMC. In metallic samples, low IL-6 levels were obtained 
with and without LPS. Only in DLC coated sample, higher IL-6 secretion than the other 
metallic samples and the control culture. Therefore, DLC coating might stimulate IL-6 
secretion from the cells. In biomaterial applications, low levels of IL-6 are the desired 
condition, because IL-6 plays important roles in inflammation. High levels of IL-6 may 
indicate the inflammatory responses in the body.  IL-6 has stimulatory effects on other 
  50 
cells such as T-cells. High or prolonged secretion of this cytokine is seen in many 
diseases including cancers.  
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Figure 4.9. The effects of BSA-coated ceramic pellets, metallic and polymeric 
biomaterials on the secretion of IL-6 from PBMC. Protein coated ceramic pellets, 
metallic samples and polymeric sample were incubated with 1ml PBMC (2.5×105 
cells/well in 24-well plates) with and without LPS (10 µg/ml) for 17 hours. The cells 
were precipitated by centrifugation and supernatants were collected. IL-6 
secretion was determined by using Quantikine human IL-6 ELISA kit. Data are 
the average of duplicate samples from one experiment. The samples with LPS 
diluted with a factor of 4. 
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Mononuclear cell cultures are used to determine the immune specific and 
aspecific responses to implant materials. Some materials can evoke immune reactions 
and it is required to remove implant from the body [108]. A variety of cytokines 
released from lymphocytes and monocytes/macrophages around an implant affect the 
response of tissues to the implant. In fact, bone remodelling is regulated through the 
release of cytokines stimulating bone resorption by the mononuclear cells [109,110]. 
Chiba et al. reported an enhanced activity of IL-1, IL-6 and TNF in tissues surrounding 
the femoral component of failed cementless total hip arthroplasties [111]. Chromium is 
a major alloying element in cobalt-chrome alloys and stainless steel. Granchi et al. 
showed that in unstimulated PBMC chromium ions slightly increased the release of IL-
6 and TNF-α, even though the increase was not significant. However, the different 
concentrations of chromium extract significantly inhibited the response to 
phytohemagglutinin (PHA) stimulation, as shown by the decrease in IL-6 and sIL-2r 
release, and by the influence on cell viability and DNA synthesis [112]. These results 
are in agreement with our results in the metallic samples.   
 
4. 3. Effects of Biomaterials on The Proliferation of PBMC 
 The proliferation of PBMC was determined by using Cell proliferation ELISA 
kit (Amersham Life Sciences). Concanavalin A (Con A) was used as a mitogen in the 
assay. For the detection of effective concentration of Con A on PBMC, different 
concentrations of Con A was incubated with the cells. At 200 µg/ml concentration of 
Con A, the proliferation of PBMC was maximum (Figure 4.10). Higher concentrations 
resulted in a decrease in the proliferation of cells. Therefore, in the test of ceramic 
materials, the optimum Con A concentration, 200 µg/ml, was used.  
PBMC were incubated with bioceramic pellets (5 mm in diameter) in the 
presence and absence of Con A. When compared to the control culture, there was a 
slight increase (1.12-fold) in the proliferation of PBMC incubated with HA 800 °C 
(Figure 4.11;Table B12). On the other hand, HA-Alumina 1250 °C and HA-Zirconia 
1250 °C caused 1.8-fold and 2.2-fold decrease, respectively in the cell proliferation. 
Other ceramic samples resulted in the cell proliferation at about the same level of the 
control culture. In the presence of Con A, all ceramic samples gave rise to a decrease in 
the proliferation of cells. Especially in the cells treated with HA 800 °C, HA-Alumina  
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1250 °C and HA-Zirconia 1250 °C samples, there was 3.1-fold, 5.7-fold and 5.7-fold 
decrease, respectively, in the cell proliferation compared to the control culture (Figure 
4.11;Table B12). In addition, in the presence of Con A, the proliferation of HA 1250 
°C, alumina 1450 °C and zirconia 1450 °C treated cells was 1.12-fold, 1.44-fold and 
1.31-fold less than that of the control culture. Interestingly, in the presence of mitogenic 
agent Con A, lower cell proliferations than the control culture in the ceramic samples 
were obtained. As in the case of cytokine secretions in the presence of LPS, dissolution 
of ceramics, released particles or ions might affect the action of these stimulatory 
agents. Low cell proliferation in HA 800 °C pellets could be explained as death of cells, 
in other words, low cell viability. However, in other ceramic samples appropriate cell 
viabilities were obtained with respect to the control cultures. These results indicated that 
HA 800 °C, HA-Alumina 1250 °C and HA-Zirconia 1250 °C samples have inhibitory 
effects on the proliferation of PBMC. Therefore, these samples are not biocompatible 
on the parameter of cell proliferation. Because the proliferation of cells after mitogen 
stimulation is indication of immune cell function. 
 
Figure 4.10. Stimulation of PBMC with Con A.  
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PBMC (2×105 cells/well in 96-well plate) were cultured in the presence different 
concentrations of Con A between 0.01 and 1000 µg/ml. Proliferation of cells were 
determined by Biotrak Cell Proliferation ELISA kit. Optical densities at 450 nm 
directly represent the proliferation of PBMC. At 200 µl/ml concentration 
maximum cell proliferation was detected. Data are the average of duplicate 
samples from the same experiment.   
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Figure 4.11. Effects of bioceramics on proliferation of PBMC. PBMC (8×104 
cells/well) were cultured with ceramic pellets (5 mm in diameter) for 72 hours. 
BrdU was added 24 hours before the end of incubation period. The incorporation 
of BrdU in proliferating cells was determined with peroxidase-labelled anti-BrdU 
antibodies. Optical densities at 450 nm were determined after addition of TMB 
substrate. OD values directly represent the proliferation of PBMC. Con A 
stimulates the cell proliferation. Effects of ceramic pellets in the presence and 
absence of Con A (200 µg/ml) were compared. Data are the average of duplicate 
samples. Test was repeated with the similar results. 
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4. 4. Effects of Biomaterials on The Activation of PBMC  
 The activation of PBMC was examined by using MTT assay. For this purpose, 
ceramic pellets (5 mm in diameter) at different sintering temperatures between 800 °C 
and 1450 °C and their extracts in PBS (pH 7.4) were used. PBMC were incubated with 
the samples at optimum cell culture conditions for 24, 48 and 72 hours. MTT in active 
cells is converted to insoluble formazan crystals that are dissolved in DMSO and the 
absorbance of formed purple solutions directly represents the cellular activity. After 24 
hours, in HA 800 °C, HA 900 °C and HA 1250 °C pellets 24%, 13% and 5% lower 
absorbance values than the control culture were obtained. On the contrary, in HA 1100 
°C, HA-Alumina 1250 °C and HA-Zirconia 1250 °C pellets 11%, 21% and 47% 
increase in the absorbance values were recorded. After 48 hours and 72 hours, all tested 
ceramic samples showed lower response than the control cultures (Figure 4.12).     
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Figure 4.12. Activation of PBMC in the presence on Hydroxyapatite samples. 
PBMC (1×105 cells/well in 96-well plates) were cultured in the presence of HA 800 
°C, HA 900 °C, HA 1100 °C, HA 1250 °C, HA-Alumina 1250 °C and HA-Zirconia 
1250 °C pellets (5 mm in diameter) at 37 °C with 5% CO2 for 24, 48 and 72 hours. 
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Cell suspensions were highlighted and transferred into blank wells. 3 hours before 
the end of incubation periods, MTT (5 mg/ml) was added into wells at 1:10 ratio 
with the culture medium. Formazan crystals were solubilized with DMSO after 
precipitation of cells by centrifugation at 1800 rpm for 10 minutes. Optical 
densities were read at 540 nm (reference wavelength 690 nm). Data are the average 
of duplicate samples from the same experiment. 
 
 Extracts of bioceramics at different concentrations and at different time points 
were tested to examine their effects on the activation of PBMC. In HA 800 °C extracts, 
after 24 hours, the cells were activated at all concentrations. However, the activation of 
cells decreased by increasing concentrations of the extracts. After 48 and 72 hours, the 
absorbance values were lower than the control cultures without any biomaterials. In HA 
900 °C extracts, like HA 800 °C samples, after 24 hours, an activation of cells were 
observed with respect to the control. However, after 48 and 72 hours, the results were 
lower than the control. After 24 hours incubation of HA 1000 °C and HA 1250 °C 
extracts with the cells, an activation of cells were obtained at all concentrations. At 48 
and 72 hours time points, the results were almost equal to the controls. In the case of 
alumina 1450 °C and zirconia 1450 °C extracts, at the 24 hours, higher absorbance 
values than the control were recorded. After 48 and 72 hours, the results were lower 
than the controls (Figure 4.13). As a result of these data, the extracts of ceramics 
activated PBMC in 24 hours and at low concentrations. Especially, at 5 µl and 10 µl of 
HA 800 °C, HA 900 °C, HA 1250 °C and alumina 1450 °C samples higher absorbance 
values than the controls were obtained. Prolonged exposure to the extracts may become 
toxic for cells and cells may start to die. Because MTT assay measures cytotoxic effects 
of test samples, low absorbance values at 540 nm represent the cytotoxic effects of 
extracts. Taken together, these results showed that even though there is a fluctuation in 
the OD levels of MTT assay based on prolonged exposure or concentration of the 
extracts, the difference among OD levels of samples is relatively low. Therefore, it can 
be concluded that biomaterials used in this assay are not toxic to PBMC. 
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Figure 4.13. Activation of PBMC in the presence of extracts of ceramic materials. 
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PBMC (1×105 cells/well) were incubated with the extracts of HA 800 °C (A), HA 
900 °C (B), HA 1000 °C (C), HA 1250 °C (D), Alumina 1450 °C (E) and Zirconia 
1450 °C (F) with concentrations of 5 µl, 10 µl, 20 µl and 40 µl at 37 °C with 5% 
CO2 for 24, 48 and 72 hours (Columns in the graphs represent concentrations of 
extracts and the last one is the control culture without any extract of biomaterials, 
respectively). 3 hours before the end of incubation periods, MTT (5 mg/ml) was 
added into wells at 1:10 ratio with the culture medium. Formazan crystals were 
solubilized with DMSO after precipitation of cells by centrifugation at 1800 rpm 
for 10 minutes. Optical densities were read at 540 nm (reference wavelength 690 
nm). Data adapted from one set of experiment. 
  
 Cytotoxicity tests are recommended for all biomaterials. These tests allow for a 
rapid evaluation and to obtain quantitative and comparable data with less expensive 
results than animal testing. In addition, due to sensitivity of the tests, they allow for 
discarding toxic materials prior to animal testing. Experimental studies showed good 
correlation between in vitro and in vivo cytotoxicity tests. The cells in vitro are more 
sensitive to toxic materials and substances than in vivo tissues. Therefore, a material 
toxic in vitro may result not actually toxic for the tissues in vivo, even in long-lasting 
assays [108].  
 
4. 5. Dissolution Properties of Biomaterials 
 There are two main classes of ceramics used as biomaterials: Structural and 
resorbable (or soluble). Alumina and zirconia are structural ceramics. Calcium 
hydroxyapatite, tricalcium phosphate, octacalcium phosphate are the soluble ceramics. 
Studies on the biomaterials-cell interactions, HA 800 °C pellets and the extracts showed 
low responses or undesired results with respect to the controls, other ceramic and 
metallic samples. The reasons of the negative effects of HA 800 °C samples were 
examined in this part. For this purpose, HA 800 °C, HA 1250 °C, alumina 1450 °C and 
zirconia 1450 °C pellets in 15 mm in diameter were incubated in the culture medium 
(RPMI-1640 containing 15% FBS and 50 µg/ml gentamycin sulfate) with and without 
PBMC and in deionized water for 4 hours, 72 hours and 10 days periods. A sample 
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solution was collected at the end of time points and it was diluted with sterile deionized 
water. The conductivity and pH of dilutions were measured.  
 In the first 4 hours, the data were taken at 1-hour intervals. Dilutions were 
carried out and measurements were taken immediately. Figure 4.14-A represents ionic 
alteration in deionized water. In 4 hours period, HA 800 °C pellets led to an increase in 
the conductivity. In HA 1250 °C pellets almost same results with deionized water were 
obtained. Also, this test was carried out for long period of time. In 10 days period, an 
increase in the conductivity of HA 800 °C pellets in deionized water were found. 
However, HA 1250 °C, zirconia 1450 °C pellets and in deionized water did not change 
the conductivity up to 10 days (Figure 4.14-B).  
 Effects of ceramic materials on conductivity were examined in the cell culture 
medium with and without cells. PBMC may act on ceramic samples to degrade them by 
phagocytosis. These events can change the ionic environment. In 4 hours period, there 
was a fluctuation in the data, but there was no sharp increase or decrease in the 
conductivity values of all samples (Figure 4.15-A). In 72 hours period, the culture 
medium without and with the cells containing HA 800 °C pellets showed an increase in 
the conductivity values with time (Figure 4.15-B). In HA 1250 °C pellets, there was 
some change in the conductivity at different time points, whereas almost no change in 
HA 1250 °C pellets was obtained in the conductivity at 72 hours. RPMI-1640 medium 
and the culture medium with the cells slightly increased the conductivity. The reason of 
that might be the production of waste products by cells or depletion of some minerals or 
ions in medium with time. HA 800 °C pellets have porous structure and they are not 
dense as much as HA 1250 °C pellets. Due to density of HA 1250 °C, alumina 1450 °C 
and zirconia 1450 °C pellets, the release of particles or ions were less than HA 800 °C 
pellets.  
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Figure 4.14. Conductivity measurement of Hydroxyapatite pellets in deionized 
water. The pellets were incubated in deionized water at 37 °C with 5% CO2 for 4 
hours. The samples were diluted with the factor of 25 (A). Ceramic pellets were 
incubated for 10 days. The measurements were multiplied with the dilution factors 
(B). Data represent the values from one set of experiment. 
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Figure 4.15. Conductivity changes of ceramic samples in the culture medium. 
  
HA 800 °C and HA 1250 °C and alumina 1450 °C pellets were incubated in RPMI-
1640 with and without PBMC (2.5×105 cells/well in 24-well plates) at 37 °C with 
5% CO2 for 4 hours (A) and 72 hours (B). 1 ml of sample was diluted with 24 ml 
deionized water and conductivity was measured by using WTW Inolab Cond Level 
2P conductivity meter. Data were obtained from one set of experiment. 
 
 In addition to conductivity measurements, pH of diluted solutions was measured. 
In the data, a fluctuation in pH values was obtained. Especially, due to deionized water, 
a stable value could not be obtained. At 72 hours period, there was a slight increase 
from 8.5 to 8.8 in the pH of dilutions of HA 800 °C in RPMI-1640 and in the culture 
medium with PBMC. However, in HA 1250 °C samples in RPMI-1640 with and 
without cells, there was almost no change in pH (7.92 at 4 hours, 8.07 at 72 hours in 
RPMI-1640 with cells and 8.04 at 4 hours, 8.12 at 72 hours in RPMI-1640 without 
cells) (Figure 4.16-A and B). 
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igure 4.16. pH variance of Hydroxyapatite samples in the culture medium with 
nd without PBMC. Hydroxyapatite pellets in 15 mm diameter were incubated in 
PMI-1640 medium with and without cells (2.5×105 cells/well in 24-well plate) at 
7 °C with 5% CO2 for 4 hours (A) and 72 hours (B). 1 ml of sample was diluted 
ith 24 ml deionized water. The pH of samples was measured by using Hanna 
nstruments HI 9321 microprocessor pH meter. Data were obtained from one set 
f experiment. 
pH measurements were also taken in long period of time. In 10 day, the pH of 
ilutions containing HA 800 °C and HA 1250 °C pellets in deionized water were 
etermined as in Figure 4.17. In HA 800 °C pellets, an increase was observed in 3 days. 
owever, after 3 days, pH values became almost stationary. Due to evaporation of 
ater at 37 °C in long period of incubation time, high dilutions were carried out to 
easure both conductivity and pH. The reason of slight decrease after 3 days in HA 800 
C pellets might be due to these dilutions. In zirconia 1450 °C samples, there was no 
hange in the pH value. In other words, it was same as in HA 1250 °C pellets, an 
ncrease in the pH values was observed. But, with time pH decreased and closed to 
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beginning pH (at time 0). In short, there was no change in HA 1250 °C pellets at the end 
of 10 days (Figure 4.17). 
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Figure 4.17. pH measurement of Hydroxyapatite pellets in deionized water. HA 
800 °C, HA 1250 °C and zirconia 1450 °C pellets were incubated in deionized 
water at 37 °C for 10 days. Every day 2 ml of samples were diluted with 22 ml 
deionized water. The pH values were measured by using Hanna Instruments HI 
9321 microprocessor pH meter. Data were obtained from one set of experiment. 
 
  64 
 In the literature, Suzuki et al. reported that biocompatible ceramics made of β–
tricalcium phosphate (TCP) were found to be actively changing their surface properties 
in the tissue culture medium [113]. The results showed that the surface structure of 
TCPs was dynamically varied by not only dissolving Ca and PO4, but also adsorbing 
various components dissolved in the culture medium (Eagle’s minimum essential 
medium (MEM) and 10% FBS/MEM). The concentrations of dissolved Ca and PO4 in 
distilled water showed that the TCP ceramic powder was highly soluble in distilled 
water. The conductivity of TCPs at the end of 6 days decreased to the values lower than 
that for the first day by immersing in 10% FBS/MEM. This situation explains the 
removal of some solutes such as proteins and minerals, from the solution by adsorbing 
onto TCPs in 10% FBS/MEM. In addition, pH of the control solutions of MEM and 
10% FBS/MEM increased gradually day by day. Because the medium contains 
NaHCO3, increases in pH of the control solutions seem to be caused by removal of CO2. 
Similarly, the decreases in dissolved Ca in MEM and 10% FBS/MEM were considered 
to be resulted from binding of Ca with carbonate. Moreover, the precipitation of 
calcium carbonate and calcium phosphate were promoted under mild alkaline 
conditions [113]. In order to elucidate the dissolution properties of our tested ceramics 
in the culture medium with and without cells, zeta potentials of the samples, the 
amounts of released Ca and PO4 to the environment and the adsorption of proteins or 
other minerals and vitamins from the culture medium have to be examined in detail. 
 
4. 6. Mutagenic Potential of Biomaterials  
 Mutagenic effects of biomaterials were examined by applying AMES test. In 
this test the extracts of test samples in PBS (pH 7.4) were used. 100 µl extract was 
mixed with 100 µl bacterial culture. In this test, Salmonella typhimurium TA 100 strain 
was used. The number of revertant colonies with background lawn were counted after 
48 hours incubation at 37 °C and compared with the positive control (sodium azide) and 
the negative control without any extracts. Data shown in Table 4.1 are average of 
replicate samples. The number of revertant colonies in the positive control was 1880. 
However, in the bacteria incubated with the extracts of all biomaterials, the number of 
revertant colonies was around that of the negative control. Based on these data, no 
mutagenic effects of extracts of biomaterials were detected (Figure 4.18). 
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Table 4.1. The number of revertant colonies of Salmonella typhimurium TA100 
 
Biomaterials TA 100 (n=2) Biomaterials TA 100 (n=2) 
HA 800 °C 79.5 Zirconia 1450 °C 105 
HA 900 °C 116 HA-Alumina 1250 °C 92.5 
HA 1000 °C 127 HA-Zirconia 1250 °C 125.5 
HA 1250 °C 112.5 Stainless steel (316L) 112.5 
HA 1400 °C 110 Ti Alloy (Ti-6Al-4V) 105 
Alumina 1000 °C 110 
Sodium Azide  
(positive control) 
1880 
Alumina 1450 °C 104.5 Neg. Control (only bacteria) 104 
Zirconia 1000 °C 84.5 Neg. Control without Histidine 39.5 
 
AMES test with Salmonella typhimurim TA100 strain was carried out in the 
presence of extracts of biomaterials. 100 µl extracts were mixed with 100 µl 
bacterium culture and poured onto glucose plates. The inoculated plates were 
incubated at 37 °C for 48 hours. The revertant colonies with background lawn 
were counted. The mutagenic potentials of extracts of biomaterials were compared 
with the positive control (sodium azide) and the negative control (only bacteria). 
Data are the average of duplicate plates from the same set of experiment. 
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4. 7. Adhesion of Pathogenic Bacteria to Biomaterial Surfaces 
 Formation of a biofilm layer on the surface of biomaterials was detected as 
described in Materials and Methods Section. For this purpose, S. aureus, E.coli that are 
the main causative agents of osteomyelitis were used. Moreover, especially in dental 
implants Viridans species (S. mutants and S. mitis) and in pacemaker implants KNS-
centred infections are mostly observed. Therefore, these bacteria species were used to 
determine their adhesion to the surface of ceramic, metallic and polymeric materials. In 
order to observe bacteria on the surface, pellets were heated on hot plate to fix bacteria. 
After that, bacteria were stained with methylene blue (Figures 4.19, 4.20, 4.21, 4.22, 
4.23, 4.25, 4.26 and 4.27) or acid fuchsin dyes (Figures 4.24 and 4.28). The surfaces of 
biomaterials were observed by a reflected light microscope and photographs were taken 
by using Olympus semiautomatic exposure photomicrography system and Kodak gold 
ultra 400/27° 35 mm film. The photographs directly represent the data. Surface 
roughness is an important parameter for bacterial adhesion. Especially smooth surfaces 
are not suitable for attachment of bacteria. Cracks, clefts and rough surface help bacteria 
to colonize on the surface as seen in Figures 4.19-4.28. Adhesion of pathogenic bacteria 
onto surface helps the formation of biomaterial-centred infections in the body. These 
conditions are undesired in the implant applications. These infections result in costly 
removal of implant material from body also affecting the patient health. 
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Figure 4.19. S. aureus on the surface of HA 800 °C pellet.  
 
 
 
 
Figure 4.20. S. aureus on the surface of HA 1250 °C pellet. 
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Figure 4.21. S. aureus on the surface of Zirconia 1450 °C pellet.  
 
 
 
Figure 4.22. S. aureus on the surface of polished stainless steel (316L). 
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Figure 4.23. S. aureus on the surface of stainless steel (316L). 
 
 
 
Figure 4.24. E. coli on the surface of stainless steel (316L). 
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Figure 4.25. E. coli on the surface of HA 1250 °C pellet. 
 
 
 
Figure 4.26. Viridans spp. (S. mitis) on the surface of stainless steel (316L). 
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Figure 4.27. KNS on the surface of polished stainless steel (316L). 
 
 
 
Figure 4.28. Streptococcus mutans on the surface of polished stainless steel (316L). 
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4. 8. Anti-bacterial Effects of Biomaterials 
 Anti-bacterial effects of biomaterials were investigated by using the agar 
diffusion method. Gram-negative bacterial strains (E. coli, P. aeruginosa, K. 
pneumonia, Proteus spp.) and gram-positive bacterial strains (S. aureus and S. 
pyogenes) were inoculated on Mueller-Hinton agar plates. The plates were incubated at 
37 °C with 5% CO2, humidified incubator. Zone diameters around test samples and the 
positive controls (antibiotic discs) were measured daily. Meropenem (10 µg) discs for 
E. coli, P. aeruginosa, K. pneumonia, Proteus spp. and S. pyogenes and vancomycin (30 
µg) discs for S. aureus were used. Any inhibition zones around HA, alumina and 
zirconia powders, HA 800 °C, HA 1000 °C, HA 1250 °C, Alumina 1450 °C, Zirconia 
1450 °C, titanium alloy, stainless steel and cirulene (ultra high molecular weight 
polyethylene) discs were not observed. The comparison between inhibition zones of 
antibiotic discs and test samples were shown in Figures 4.29 and Figure 4.30. In this 
test, the test sample should be dissolve in the agar medium to inhibit bacterial growth. 
However, none of the test samples was soluble in the agar medium. Most possibly the 
solid forms resulted in these results. As a result of the data, tested biomaterials had no 
anti-bacterial effect on various pathogenic bacteria. 
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Figure 4.29. Inhibition zone around vancomycin disc and the test materials on S. 
aureus plate after 24 hours incubation. 
 
Figure 4.30. Inhibition zone around meropenem disc and the test materials on 
Pseudomonas aeruginosa plate after 24 hours incubation. 
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Chapter 5 
 
CONCLUSIONS AND FUTURE EXPERIMENTS 
 
5. 1. Conclusions 
 In summary, ceramic materials (hydroxyapatite, alumina and zirconia), their 
extracts in PBS, ceramic-ceramic composites (HA-Alumina and HA-Zirconia), metallic 
materials (stainless steel and titanium alloy) and polymeric material (high molecular 
weight polyethylene (cirulene)) with different chemical and surface properties were 
examined to determine their effects on the viability, proliferation and activation of 
PBMC and on the secretion of inflammatory cytokines (IL-1α and IL-6) from PBMC. 
Furthermore, the mutagenic potential of extracts of biomaterials, anti-bacterial effects 
and adhesion of pathogenic bacteria to the surface of biomaterials were investigated. 
Finally, to elucidate the effects of biomaterials in the cell culture, the dissolution 
properties of ceramic samples in the culture medium and in deionized water were 
investigated on the basis of pH and conductivity measurements. 
 In conclusion, the sintering temperature of HA pellets showed an effect on the 
cell viability. HA pellets sintered at 800 °C, 900 °C, 1000 °C resulted in a decrease in 
the viability of PBMC, but HA 1100 °C and HA 1250 °C pellets had no effects on the 
viability compared to the control culture. However, BSA-coated HA 800 °C pellets 
increased the cell viability with respect to uncoated HA 800 °C pellets. Especially 
polished metallic samples and other metallic and polymeric samples showed high 
percent cell viabilities at 24 and 48 hours. However, after 72 hours, a decline in the cell 
viabilities was determined most probably due to released ions and particles to the 
environment. A negative correlation between increasing extract concentration and the 
cell viability was observed for all ceramic samples especially after 48 and 72 hours 
treatments. As a result, except for HA 800 °C samples, all samples led to appropriate 
percent cell viabilities at all incubation periods with respect to the control cultures. 
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 The secretion of inflammatory cytokines from PBMC in the presence of 
biomaterials was examined by using ELISA kits. In the presence of LPS, a decrease in 
IL-1α secretion was observed in HA 800 °C, HA-Alumina 1250 °C and HA-Zirconia 
1250 °C pellets. BSA-coated of HA 800 °C pellets did not change IL-1α secretion in the 
presence of LPS. However, in the absence of LPS, BSA-coating caused an increase in 
IL-1α secretion in HA 800 °C pellets. Unlike HA 800 °C, BSA-coating of HA 1250 °C, 
alumina 1450 °C and zirconia 1450 °C showed higher levels of IL-1α secretion in the 
presence of LPS. Stainless steel, titanium alloy and cirulene pellets resulted in low 
levels of IL-1α secretion. Because IL-1α secretion is an indication of inflammation, low 
level of IL-1α secretion in the presence of biomaterials is favorable condition.  
Therefore, metallic biomaterials and cirulene seems to be desired biomaterials. In the 
case of IL-6, BSA-coated HA 800 °C pellets increased IL-6 secretion compared to 
uncoated pellets. In metallic samples, low IL-6 levels were obtained with and without 
LPS indicating that the metallic samples and cirulene are more biocompatible than 
BSA-coated ceramics. 
HA 800 °C, HA-Alumina 1250 °C and HA-Zirconia 1250 °C samples had 
inhibitory effect on the proliferation of PBMC. Especially in the presence of Con A, HA 
800 °C, HA-Alumina 1250 °C and HA-Zirconia 1250 °C samples led to significant 
decreases in the proliferation of cells with respect to other ceramic samples and the 
control culture. Therefore, these samples are not biocompatible on the parameter of cell 
proliferation. The inhibition of proliferation of PBMC in the presence of a mitogen by 
biomaterials may cause immune suppression and this may lead to be the body 
susceptible to infections.  
The results of MTT assay represent both activation of PBMC and cytotoxic 
potentials of test samples on PBMC. As in the case of cell viabilities, HA 800 °C and 
HA 900 °C samples showed the lowest cell activation at all incubation periods. 
Moreover, other ceramic samples showed lower cell activation after 48 and 72 hours 
treatments compared to the control cultures. In addition, the extracts of ceramics 
activated PBMC in 24 hours and at low concentrations. Especially, at 5 µl and 10 µl of 
HA 800 °C, HA 900 °C, HA 1250 °C and alumina 1450 °C samples higher absorbance 
values than the controls were obtained. Prolonged exposure to the extracts may become 
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toxic for cells and cells may start to die. Although there was a fluctuation in the OD 
levels of MTT assay based on prolonged exposure or concentration of the extracts, the 
difference among OD levels of samples was relatively low. Therefore, it can be 
concluded that the extracts of biomaterials used in this assay are not toxic to PBMC, but 
the pellets sintered at low temperatures may be toxic to PBMC due to released products 
in the dissolution process. 
The dissolution properties of ceramic samples were determined in deionized 
water and in the culture medium with and without PBMC. In deionized water, HA 800 
°C pellets showed a significant increase in the conductivity. However, in HA 1250 °C, 
zirconia 1450 °C and in deionized water itself, there was almost no change up to 10 
days period. In the culture medium with and without PBMC, HA 800 °C pellets led to 
an increase in the conductivity. In other samples, there were no significant alterations in 
the conductivity during overall incubation periods. Whereas, in the pH values of 
samples in the culture medium with and without the cells and in deionized water, there 
were fluctuations. Only HA 800 °C samples in the culture medium with and without the 
cells resulted in a slight increase in pH of solutions in 4 and 72 hours periods. Only HA 
800 °C pellets caused an increase in the pH of deionized water up to 10 days. As a result 
of these measurements, some ion transfers take place both from materials to medium 
and from medium to materials. The released ions increased the conductivity and pH of 
solutions that may be the reasons of death of cells in the presence of HA 800 °C pellets. 
According to results of AMES reverse mutation test, none of the extracts of 
biomaterials in PBS had mutagenic effects on Salmonella typhimurium TA100 strain 
when they were compared to the mutagenic material (sodium azide) and the negative 
controls (only bacteria). 
None of the tested ceramic powders, ceramic pellets, metallic and polymeric 
materials has anti-bacterial effects on both gram-negative strains (E. coli, P. aeruginosa, 
K. pneumonia, Proteus spp.) and gram-positive strains (S. aureus and S. pyogenes). 
Furthermore, in adhesion of pathogenic bacteria to the surface of biomaterials, it was 
found that surface properties, especially roughness and characteristics of materials are 
important for attachment, adhesion and colonization of bacteria on the surface of 
biomaterials. 
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5. 2. Future Experiments 
1. Determination the conductivity, pH alterations and zeta potentials of BSA-
coated ceramic samples in dH2O, the culture medium with and without cells may 
be useful to elucidate the positive effect of BSA adsorption onto ceramic pellets.  
2. Adsorption of different proteins or biologically active molecules onto ceramic, 
metallic and polymeric samples may be carried out to investigate the effects of 
these coating materials on different cell types and adhesion of pathogenic 
bacteria to the surface of materials. 
3. Films from organic and inorganic sources may be produced and they may be 
loaded with antibiotics and coated to the surface of biomaterials to prevent 
bacterial attachment and adhesion. 
4. New ceramic-ceramic, ceramic-metallic, ceramic-polymeric composite materials 
may be produced from biocompatible materials with desired chemical, physical 
and mechanical properties. 
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APPENDIX A
PROCEDURES OF TESTS
Take 10 ml blood into heparinized needle with 400 µl heparin-sodium solution (50 I.U.)
Transfer blood into 2 sterile tubes and add equal volume of sterile 0.9% NaCl
Take 5 ml of NaCl-blood mixture and layer onto 3 ml Ficoll solution very slowly
Centrifuge the tubes at 1600 rpm, at room temperature for 25 minutes
Transfer the buffy coat layer into new tubes and add 4-5 volumes of PBS (pH 7.4)
containing 2% FBS
Centrifuge the cells at 800 rpm for 10 minutes at RT
Remove the supernatant and resuspend the pellet with 10 ml PBS containing 2% FBS
Centrifuge the cells at 500 rpm for 8 minutes at RT
Repeat the washing once more to remove thrombocytes and platelets
Resuspend the pellet in 2 ml RPMI-1640 medium (pH 7.4) containing 15% FBS and
50 µg/ml gentamycin sulfate
Determine isolated cell number by mixing 50 µl cell suspension with
50 µl trypan blue solution (0.4 %)
Count the cells in 25 squares of hemocytometer by using light microscope
Calculate the number of cells/ml
Number of cells/ml = Number of cells counted in 25 square × Dilution factor × 104
Figure A1. Isolation of PBMC procedure
AA2
Incubate PBMC (2.5×105 cells/ml) with biomaterials at 15 mm in diameter in 24-well
plates. Incubate PBMC (1×105 cells/well) with the extracts of biomaterials in 96-well
flat bottom tissue culture treated plates.
Incubation was carried out for 24, 48 and 72 hours at 37 °C with 5% CO2,
humidified incubator.
Collect the cell suspensions into eppendorf tubes and centrifuge at 100 rpm for 10 min.
Remove the supernatant until 100-200 µl remained in eppendorf tubes
Resuspend the cells slowly and mix 50 µl of the cell suspension with
50 µl trypan blue solution (0.4 %)
Count live and dead cells immediately by using hemocytometer under light microscope
Calculate the percent viability of cells by the following formula:
Percent Cell Viability = [Number of live cells / Number of total cells (live+dead)] × 100
Figure A2. Trypan blue exclusion method
AA3
Incubate the samples with 1×105 cells/well in 96-well tissue culture treated plates for 24
hours, 48 hours and 72 hours at 37 °C with 5% CO2, humidified incubator
Add MTT stock solution (5 mg/ml) into each well at 1:10 ratio
for last 3 hours of incubation period
Centrifuge the plate at 1800 rpm for 10 minutes at room temperature
Remove the supernatants by tapping slowly on a paper towel
Add DMSO (150 µl) into each well and mix on an orbital shaker at 150 rpm for 5 min.
Measure the absorbance values at 540 nm (690 nm reference wavelength)
by using an automated plate reader
Figure A3. MTT assay
AA4
Grow Salmonella typhimurium strain TA 100 in nutrient broth no:2 in test tubes or in 50
ml flasks at 37 °C with shaking overnight in a thermal shaker
Mix 0.5 ml PBS (pH: 7.4), 0.1 ml of bacterial culture and 0.1 ml biomaterial extracts
by vortex and incubate for 1 hour at 37 °C with shaking
Add 2 ml top agar containing 0.5 mM Histidine-Biotin into tubes and
mix slowly by vortexing at low speed for 3 seconds
Pour onto glucose agar plates immediately
Incubate duplicate plates at 37 °C for 48 hours and
count the revertant colonies with background lawn
Compare the number of revertant colonies in the negative control (no extract), in the
positive control (sodium azide for TA100) plates and in the plates with top agar
containing only biotin for the mutagenic potentials of samples
Figure A4. AMES test
AA5
Place dry heat sterilized metallic and ceramic pellets in polystyrene, 90 mm in diameter,
sterile, 4 partitioned plates
Add 6 ml of LB broth (pH: 7.4) for S. aureus, E.coli and KNS strains, 6 ml of BacT
Medium for Viridans strains into each partition of plates
Prepare dilutions of bacterial suspensions in sterile dH2O according to McFarland 0.5
(108 CFU/ml) and add 0.1 ml into each part
Incubate the plates with S. aureus and E. coli for 6 hours and the plates with Viridans
and KNS for overnight at 37 °C with shaking at 40 rpm in a thermal shaker
Wash the pellets with sterile dH2O 4-5 times
Air dry the pellets and fix bacteria on the pellets on hot plate for 30 seconds
or at 60 °C for 1 hour
Stain bacteria with methylene blue or acid fuchsin (Bacto TB carbolfuchsin KF) for 30
seconds and wash with dH2O to remove excess dye
Air dry and examine under an optical microscope
Figure A5. Determination the adhesion of bacteria to biomaterial surfaces
APPENDIX B
TABLES OF DATA
Table B1. Effects of ceramic biomaterials on the viability of PBMC
 Percent Viability of PBMC
Test Sample 24 hours 48 hours 72 hours
Control
(Without Biomaterial)
96.12 94.06 85.43
HA 800 °C 72.62 28.22 22.13
HA 1250 °C 96.22 94.63 91.00
Alumina 1450 °C 94.90 93.86 87.33
Zirconia 1450 °C 96.15 96.77 93.14
HA 800 °C, HA 1250 °C, alumina 1450 °C and zirconia 1450 °C ceramic samples (15 mm in
diameter) were incubated with 2.5×105 cells/well at 37 °C with 5% CO2 for 24, 48 and 72 hours.
Live and dead cells were counted after staining with trypan blue (0.4%) and percent cell viabilities
were calculated. Data are the average of duplicate samples from separate experiments and from
different donors.
AB2
Table B2. Effects of different sintering temperature of ceramic pellets
on the viability of PBMC
Percent Viability of PBMC
Test Sample 24 hours 48 hours 72 hours
Control 94.12 92.12 86.36
HA 800 °C 57.25 29.90 32.23
HA 900 °C 54.52 35.63 30.95
HA 1000 °C 66.81 58.92 28.26
HA 1100 °C 94.12 89.10 83.94
HA 1250 °C 98.00 90.76 82.58
Alumina 1000 °C 84.81 48.51 ND
Alumina 1450 °C ND 84.85 ND
PBMC (2×105 cells/well) were incubated with ceramic samples with different sintering
temperatures (15 mm in diameter) at 37 °C with 5% CO2 for 24, 48 and 72 hours. The percent cell
viabilities were determined by trypan blue exclusion method. Data are the average of duplicate
samples from separate experiments. ND: not determined.
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Table B3. Effects of ceramic extracts on the viability of PBMC
Percent Cell Viability
HA 800°C HA 1250 °C Al 1450°C Zir 1450°C
5 µl extract 93.80 98.49 86.33 94.39
10 µl extract 97.98 93.86 91.40 91.67
20 µl extract 96.64 96.67 93.18 90.62
40 µl extract 92.59 90.72 92.31 93.10
24
 h
ou
rs
Control (Without Extract) 92.70
5 µl extract 92.86 90.00 92.78 93.10
10 µl extract 92.91 91.34 90.00 81.82
20 µl extract 83.82 95.04 82.05 87.50
40 µl extract 85.98 90.84 90.35 84.214
8 
ho
ur
s
Control (Without Extract) 90.48
5 µl extract 88.54 91.84 88.04 85.38
10 µl extract 78.81 90.42 83.71 84.18
20 µl extract 84.68 91.27 89.10 88.51
40 µl extract 68.96 86.81 90.77 88.967
2 
ho
ur
s
Control (Without Extract) 91.65
PBMC (1×105 cells/well) were incubated with different concentrations of ceramic
extracts in PBS at 37 °C with 5% CO2 for 24, 48 and 72 hours periods. Percent cell
viabilities were determined by trypan blue exclusion method. Data are the average
of duplicate samples from separate experiments.
AB4
Table B4. The viability of PBMC after incubating
with protein adsorbed ceramic pellets
Percent Viability of PBMC
Test Sample 24 hours 48 hours 72 hours
Control (Without Biomaterial) 97.92 95.73 88.24
HA 800 °C 82.14 57.14 35.90
HA 1250 °C 97.03 90.53 87.74
Alumina 1450 °C 94.87 89.60 89.55
Zirconia 1450 °C 98.98 94.74 85.71
Bovine Serum Albumin (BSA) adsorbed ceramic pellets (15 mm in diameter) were incubated in 10
ml protein solution with the concentration of 20 mg/ml BSA in sodium phosphate buffer (pH 7.3) at
37 °C with shaking at 110 rpm for 3 hours. The pellets were incubated with 1 ml PBMC (2.5×105
cells/well) at 37 °C with 5% CO2 for 24, 48 and 72 hours. The viabilities of cells were determined
trypan blue exclusion method. Data for protein adsorbed ceramic samples represent results of one
experiment.
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Table B5. Effects of metallic and polymeric samples on the viability of PBMC
Percent Cell Viabilities
Test Sample 24 hours 48 hours 72 hours
Control (Without Biomaterial) 94.40 89.98 90.18
Stainless Steel (316L) 94.64 90.36 70.48
Polished Stainless Steel 100 100 85.53
Titanium Alloy (Ti-6Al-4V) 96.12 87.70 80.98
Polished Titanium Alloy 95.24 87.23 86.21
Cirulene
(ultra high molecular weight PE)
95.30 89.91 75.52
Metallic biomaterials stainless steel (316L), titanium alloy (Ti-6Al-4V) and their
polished forms with 1200 grid SiC, 6 micron diamond solution, 1 and 0.5 micron
alumina suspension and polymeric material cirulene were examined with PBMC.
2×105 cells/well in 24-well tissue culture treated plates incubated with 10 mm
sample discs at 37 °C with 5% CO2 for 24, 48 and 72 hours. Percent cell viabilities
were determined by using trypan blue exclusion method. Data are the average of
duplicate samples from separate experiments.
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Table B6. Effects of biomaterials on the secretion of IL-1α from PBMC
with and without LPS stimulation
Biomaterial
OD value @450 nm
without LPS
OD value @450 nm with
LPS
Control
HA 800 °C
HA 1250 °C
Zirconia 1450 °C
Alumina 1450 °C
HA-Alumina 1250 °C
HA-Zirconia 1250 °C
0.072
0.074
0.078
0.078
0.074
0.073
0.077
0.818
0.160
0.751
0.785
0.662
0.255
0.420
Table B7. Effects of metallic, polymeric and protein adsorbed ceramic samples on
the secretion of IL-1α from PBMC with and without LPS stimulation
Biomaterial
OD value @450 nm
without LPS
OD value @450 nm with
LPS
Control (Without Biomaterial)
HA 800 °C with prt adsorption
HA 1250 °C with prt adsorption
Alumina 1450 w/prt adsorption
Zirconia 1450 w/prt adsorption
Stainless steel (316L)
Titanium alloy (Ti-6Al-4V)
Cirulene (UHMWPE)
0,057
0,151
0,097
0,090
0,101
0,064
0,066
0,074
0,484
0,337
0,520
0,524
0,584
0,340
0,438
0,374
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 Figure B1. Calibration curve of IL-1α.
IL-1α calibration curve was obtained by using serial dilution of standard IL-1α,
which is supplied by the manufacturer. 0, 1.95, 3.9, 7.8, 15.6, 31.2, 62.5 and 125
pg/ml IL-1α were used. Optical densities of standards were determined as test
samples described by the manufacturer. Data are the average of triplicate
standard samples from two experiments.
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Table B8. The amount of IL-1α secretions from PBMC in the presence of biomaterials
Biomaterial IL-1α (pg/ml)
(in the presence of LPS)
Control (Without Biomaterial) 89.59
HA 800 °C 8.36
HA 1250 °C 81.32
Alumina 1450 °C 70.33
Zirconia 1450 °C 85.52
HA-Alumina 1250 °C 20.09
HA-Zirconia 1250 °C 40.46
Control (Without Biomaterial) 48.36
HA 800 °C with protein 30.21
HA 1250 °C with protein 52.80
Alumina 1450 °C with protein 53.30
Zirconia 1450 °C with protein 60.70
Stainless steel 30.58
Titanium alloy 42.68
Cirulene 34.78
Data were calculated on the basis of calibration curve of IL-1α (Figure B1).
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Table B9. Effects of biomaterials on the secretion of IL-6 from PBMC
Biomaterial
OD @ 450 nm
 without LPS
Control
HA 800 °C
HA 1250 °C
Zirconia 1450 °C
Alumina 1450 °C
HA-Alumina 1250 °C
HA-Zirconia 1250 °C
1.029
0.371
1.042
1.171
1.066
0.876
0.780
Table B10. Effects of protein coated ceramic, metallic and polymeric samples
on IL-6 secretion from PBMC
Biomaterial OD @450 nm OD @450 nm with LPS
Control (Without Biomaterial) 0.392 2.600
HA 800 °C with prt coating 2.939 1.918
HA 1250 °C with prt coating Out 2.678
Alumina 1450 °C with prt coating 2.928 2.776
Zirconia 1450 °C with prt coating Out 2.702
Stainless Steel (316L) 0.310 2.279
Titanium Alloy (Ti-6Al-4V) 0.453 2.361
DLC coated AISI 52100 0.956 N.D.
Cirulene (UHMWPE) 0.360 2.368
Data are the average of duplicate samples from the same experiments. Samples containing LPS
were diluted 4 times before ELISA experiment. Out represents out of range of automated plate
reader at 450 nm. ND: not determined.
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Figure B2. Calibration curve of IL-6
IL-6 calibration curve was obtained by using serial dilution of standard IL-6,
which is supplied by the manufacturer. 0, 3.12, 6.25, 12.5, 25, 50 and 100 pg/ml IL-
6 were used. Optical densities of standards were determined as test samples
described by the manufacturer. Data are the average of triplicate standard
samples from two experiments.
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Table B11. The amount of IL-6 secretion from PBMC in the presence of biomaterials
Biomaterial IL-6 (pg/ml)
IL-6 (pg/ml)
(in the presence of LPS)
Control (Without Biomaterial) 111.52 -
HA 800 °C 30.28 -
HA 1250 °C 113.12 -
Zirconia 1450 °C 129.05 -
Alumina 1450 °C 116.09 -
HA-Alumina 1250 °C 92.63 -
HA-Zirconia 1250 °C 80.78 -
Control (Without Biomaterial) 32.88 1221.88
HA 800 °C with prt coating 347.32 885.07
HA 1250 °C with prt coating - 1260.40
Alumina 1450 °C with prt coating 345.96 1308.79
Zirconia 1450 °C with prt coating - 1272.25
Stainless Steel (316L) 22.75 1063.36
Titanium Alloy (Ti-6Al-4V) 40.41 1103.85
DLC coated AISI 52100 102.51 -
Cirulene (UHMWPE) 28.92 1107.31
Data were calculated on the basis of calibration curve of IL-6 (Figure B2).
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Table B12. Proliferation of PBMC with and without Con A stimulation
after treatment with bioceramics
Biomaterial
OD @ 450 nm
(PBMC without Con A)
OD @ 450 nm
(PBMC with Con A)
Control (Without Biomaterial)
HA 800 °C
HA 1250 °C
Alumina 1450 °C
Zirconia 1450 °C
HA-Alumina 1250 °C
HA-Zirconia 1250 °C
0.278
0.310
0.284
0.253
0.283
0,154
0,127
1.624
0.518
1.450
1.131
1.244
0,286
0,287
Proliferation of PBMC in the presence of ceramic pellets in 5 mm diameter was
determined by using Biotrak Cell Proliferation ELISA kit. Con A (200 µg/ml) was
used as a mitogen.  PBMC (8×104 cells/well) were cultured at 37 °C with 5% CO2
for 72 hours. BrdU was added 24 hours before the end of incubation period. The
incorporation of BrdU in proliferating cells was determined with peroxidase-
labelled anti-BrdU antibodies. Optical densities at 450 nm were determined after
addition of TMB substrate. OD values directly represent the proliferation of cells.
Effects of ceramic pellets in the presence and absence of Con A were compared.
Data are the average of duplicate samples. Test repeated three times with the cells
of different donors.
APPENDIX C
MEDIUM AND SOLUTION FORMULAS
Mammalian cell culture medium and solutions:
0.9 % Sodium Chloride: Dissolve 9 g NaCl in distilled or deionized water to a
total volume of 1 liter. Autoclave and store at +4 °C.
Phosphate-buffered saline (PBS), pH 7.4: Dissolve 0.34 g KH2PO4, 1.58 g K2HPO4 and 8.0 g
NaCl in distilled or deionized water, adjust pH to 7.4 and bring to a total volume 1 liter. Autoclave and
store at +4 °C.
Heparin solution: Prepare 50 I.U./ml stock solution with sterile 0.9% NaCl. Take 400 µl (50
I.U./ml stock) into 10 ml needle to obtain 2 I.U./ml heparin in blood. Store heparin solution at +4 °C.
Growth medium: Add 45 ml FBS (15%) and gentamycin sulfate with final concentration 50
µg/ml to 300 ml RPMI-1640. Keep growth medium and gentamycin sulfate at 4 °C. Prepare gentamycin
sulfate stock solution with sterile ultrapure deionized water. Store FBS at –20 °C and bring to 37 °C all
growth medium constituents before use.
Lipopolysaccharide from E.coli 055:B5 (LPS): Dissolve 1 mg LPS in 2 ml sterile PBS for 0.5
mg/ml stock. A final concentration of 10 µg/ml was used in cell culture. Store at  +4 °C.
Protein adsorption solutions:
Phosphate buffer, pH 7.3: Dissolve 0.69 g NaH2PO4.H2O in 250 ml dH2O and 0.7098 g
Na2HPO4 in 250 ml dH2O separately. Take 23 ml NaH2PO4.H2O and 77 ml Na2HPO4 and adjust pH to 7.3
and complete to 200 ml with dH2O to obtain 0.01 M buffer. Autoclave and store at +4 °C.
Protein solution: Add appropriate amount of BSA with aseptic conditions to yield a final
concentration of 20 mg/ml into sterile phosphate buffer (pH 7.3). Put a sterile magnet to mix protein.
Store at +4 °C.
AC2
Cell proliferation solutions :
Concanavalin A (Con A) solution: Dissolve 5 mg Con A in 2.5 ml sterile 0.9% NaCl to obtain 2
mg/ml stock solution. Store at –20 °C.
Bacterial culture medium and solutions:
Dissolve 12.5 g of LB broth and 20 g LB agar in dH2O. Adjust the pH of the media to 7.4 with 1
M NaOH or 1M HCl. Complete the volume to 500 ml with dH2O and autoclave at 121 °C for 15 minutes.
Dissolve 10.5 g of Mueller-Hinton broth (Oxoid CM 405) and 19 g Mueller-Hinton agar (Oxoid
CM 337) in dH2O. Adjust the pH of the media to 7.2-7.4 with 1 M NaOH or 1M HCl. Complete the
volume to 500 ml with dH2O. Bring to boil Mueller-Hinton agar to dissolve completely and autoclave at
121 °C for 15 minutes.
Dissolve 12.5 g of Nutrient Broth No:2 (Oxoid CM 67) in dH2O. Adjust the pH of the media to
7.4 with 1 M NaOH or 1M HCl. Complete the volume to 500 ml with dH2O and autoclave at 121 °C for
15 minutes.
Mutagenicity assay solutions:
Vogel-Bonner medium E (50X) (per liter):  670 ml Warm dH2O (45 °C)
10 g MgSO4⋅7 H2O
100 g Citric acid monohydrate
500 g K2HPO4 (anhydrous)
175 g NaHNH4 PO4 ⋅ 4 H2O
Add salts in the order indicated above to warm water in a beaker or flask placed on a hot plate with
stirring. Dissolve completely each salt before adding the next. Adjust the volume 1 liter. Distribute into 2
1-liter flasks and autoclave at 121 °C for 20 minutes.
0.5 mM Histidine/Biotin solution
(per 250 ml): 30.9 mg d-Biotin (F.W. 247.3)
24 mg L-Histidine⋅HCl (F.W. 191.7)
250 ml dH2O
Dissolve the biotin by heating the water to the boiling point. Add histidine and mix well. Autoclave or
sterilize by filtration through a 0.22-µm membrane filter. Store in a glass bottle at +4 °C. (Add 10 ml
His/Biotin solution to 100 ml of top agar)
Top agar (per liter): 6 g Agar
5 g NaCl
1000 ml dH2O
AC3
Mix thoroughly and transfer 100-ml aliquots. Autoclave for 20 minutes and cool the top agar. Store at
room temperature. Melt the top agar before using and bring to 45 °C before using mutagenicity assay.
Minimal glucose plates (per liter): 15 g Agar
930 ml dH2O
20 ml 50X VB salts
50 ml 40% Glucose
Add 15 g agar to 930 ml dH2O and autoclave for 20 minutes using slow exhaust. When agar solution has
cooled slightly, add 20 ml sterile 50X VB salts and 50 ml 40% glucose. A magnetic bar was added to the
flask before autoclaving. Mix well all the ingredients. Pour 25 ml into each petri plate. Store plates at +4
°C.
40% Glucose: Dissolve 40 g glucose in dH2O by mixing and heating on a hot plate. Autoclave
and store at room temperature.
Turbidity standard for inoculum preparations:
BaSO4 turbidity standard equivalent to McFarland 0.5 is used. 0.5 ml 0.048 mol/l BaCl2 (1.175
% w/v BaCl2⋅H2O) is added to 99.5 ml 0.18 mol/l (0.36 N) H2SO4 (1% v/v) with constant stirring to
maintain a suspension. The absorbance of prepared solution should be 0.08-0.10 at 625 nm for McFarland
0.5 standard solution. Standard solution is stored in the dark at room temperature after 4- to 6-ml aliquots
in tubes, which are tightly sealed.
MTT stock solution:
Dissolve MTT dye at a concentration of 5 mg/ml in sterile phosphate-buffered
saline (PBS) and filter through a 0.22 µm filter to remove any formazan crystals.
Aliquot and store MTT stock solution at –20 °C in the dark.
